<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Negl Trop Dis</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosntds</journal-id><journal-title-group><journal-title>PLoS Neglected Tropical Diseases</journal-title></journal-title-group><issn pub-type="ppub">1935-2727</issn><issn pub-type="epub">1935-2735</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4288732</article-id><article-id pub-id-type="pmid">25569707</article-id><article-id pub-id-type="publisher-id">PNTD-D-14-00640</article-id><article-id pub-id-type="doi">10.1371/journal.pntd.0003398</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and Life Sciences</subject><subj-group><subject>Computational Biology</subject><subj-group><subject>Population Modeling</subject><subj-group><subject>Infectious Disease Modeling</subject></subj-group></subj-group></subj-group><subj-group><subject>Veterinary Science</subject><subj-group><subject>Veterinary Diseases</subject><subj-group><subject>Zoonoses</subject><subj-group><subject>Hemorrhagic Fevers</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Arenaviruses</subject><subj-group><subject>Lassa Virus</subject></subj-group></subj-group><subj-group><subject>Hemorrhagic Fever Viruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Population Biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Lassa Fever</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Research and Analysis Methods</subject><subj-group><subject>Mathematical and Statistical Techniques</subject><subj-group><subject>Mathematical Models</subject></subj-group></subj-group><subj-group><subject>Simulation and Modeling</subject><subj-group><subject>Mathematical Modeling</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Using Modelling to Disentangle the Relative Contributions of Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever</article-title><alt-title alt-title-type="running-head">Zoonotic and Anthroponotic Transmission: The Case of Lassa Fever</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lo Iacono</surname><given-names>Giovanni</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cunningham</surname><given-names>Andrew A.</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fichet-Calvet</surname><given-names>Elisabeth</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Garry</surname><given-names>Robert F.</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref><xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Grant</surname><given-names>Donald S.</given-names></name><xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Khan</surname><given-names>Sheik Humarr</given-names></name><xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref><xref ref-type="author-notes" rid="fn1">
<sup>&#x02020;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Leach</surname><given-names>Melissa</given-names></name><xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Moses</surname><given-names>Lina M.</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Schieffelin</surname><given-names>John S.</given-names></name><xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shaffer</surname><given-names>Jeffrey G.</given-names></name><xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Webb</surname><given-names>Colleen T.</given-names></name><xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>James L. N.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Veterinary Medicine, Disease Dynamics Unit, University of Cambridge, Cambridge, United Kingdom</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Institute of Zoology, Zoological Society of London, London, United Kingdom</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Bernhard-Nocht Institute of Tropical Medicine, Hamburg, Germany</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Department of Microbiology and Immunology, Tulane University, New Orleans, Louisiana, United States of America</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Broad Institute, Cambridge, Massachusetts, United States of America</addr-line>
</aff><aff id="aff6">
<label>6</label>
<addr-line>Zalgen Labs, LLC, Germantown, Maryland, United States of America</addr-line>
</aff><aff id="aff7">
<label>7</label>
<addr-line>Lassa Fever Program, Kenema Government Hospital, Kenema, Sierra Leone</addr-line>
</aff><aff id="aff8">
<label>8</label>
<addr-line>Institute of Development Studies, University of Sussex. Brighton, United Kingdom</addr-line>
</aff><aff id="aff9">
<label>9</label>
<addr-line>Sections of Infectious Disease, Departments of Pediatrics and Internal Medicine, School of Medicine, Tulane University, New Orleans, Louisiana, United States of America</addr-line>
</aff><aff id="aff10">
<label>10</label>
<addr-line>Department of Biostatistics and Bioinformatics, Tulane School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America</addr-line>
</aff><aff id="aff11">
<label>11</label>
<addr-line>Department of Biology, Colorado State University, Fort Collins, Colorado, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>McElroy</surname><given-names>Anita K.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>CDC, United States of America</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>gl334@cam.ac.uk</email></corresp><fn fn-type="COI-statement"><p>RFG is affiliated with Zalgen Labs. This does not alter our adherence to all PLOS NTDs policies on sharing data and materials. All other authors have no competing interests.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: GLI AAC EFC ML CTW JLNW. Performed the experiments: GLI CTW. Analyzed the data: GLI CTW. Wrote the paper: GL AAC EFC LMM ML CTW JLNW. Provided and processed the data from Kenema Governament Hospital: RFG DSG SHK LMM JSS JGS.</p></fn><fn id="fn1" fn-type="other"><p>&#x02020; Deceased.</p></fn></author-notes><pub-date pub-type="collection"><month>1</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>8</day><month>1</month><year>2015</year></pub-date><volume>9</volume><issue>1</issue><elocation-id>e3398</elocation-id><history><date date-type="received"><day>16</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>7</day><month>11</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; 2015 Lo Iacono et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Lo Iacono et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Background</title><p>Zoonotic infections, which transmit from animals to humans, form the majority of new human pathogens. Following zoonotic transmission, the pathogen may already have, or may acquire, the ability to transmit from human to human. With infections such as Lassa fever (LF), an often fatal, rodent-borne, hemorrhagic fever common in areas of West Africa, rodent-to-rodent, rodent-to-human, human-to-human and even human-to-rodent transmission patterns are possible. Indeed, large hospital-related outbreaks have been reported. Estimating the proportion of transmission due to human-to-human routes and related patterns (<italic>e.g.</italic> existence of super-spreaders), in these scenarios is challenging, but essential for planned interventions.</p></sec><sec><title>Methodology/Principal Findings</title><p>Here, we make use of an innovative modeling approach to analyze data from published outbreaks and the number of LF hospitalized patients to Kenema Government Hospital in Sierra Leone to estimate the likely contribution of human-to-human transmission. The analyses show that almost <inline-formula><inline-graphic xlink:href="pntd.0003398.e001.jpg"/></inline-formula> of the cases at KGH are secondary cases arising from human-to-human transmission. However, we found much of this transmission is associated with a disproportionally large impact of a few individuals (&#x02018;super-spreaders&#x02019;), as we found only <inline-formula><inline-graphic xlink:href="pntd.0003398.e002.jpg"/></inline-formula> of human cases result in an effective reproduction number (<italic>i.e.</italic> the average number of secondary cases per infectious case) <inline-formula><inline-graphic xlink:href="pntd.0003398.e003.jpg"/></inline-formula>, with a maximum value up to <inline-formula><inline-graphic xlink:href="pntd.0003398.e004.jpg"/></inline-formula>.</p></sec><sec><title>Conclusions/Significance</title><p>This work explains the discrepancy between the sizes of reported LF outbreaks and a clinical perception that human-to-human transmission is low. Future assessment of risks of LF and infection control guidelines should take into account the potentially large impact of super-spreaders in human-to-human transmission. Our work highlights several neglected topics in LF research, the occurrence and nature of super-spreading events and aspects of social behavior in transmission and detection.</p></sec></abstract><abstract abstract-type="summary"><title>Author Summary</title><p>Many pathogens have the ability to infect different species. Lassa fever virus is an important example; this virus infects a species of rodent in West Africa, and can cause a severe disease in people. Lassa fever virus is transmitted from rodent-to-rodent, rodent-to-human, human-to-human and perhaps human-to-rodent. So far, the relative importance of these routes has not been assessed. Here we focus on the risk for humans; undoubtedly, most human infections are acquired by contact with rodents or their urine, but the relative risk of rodent-to-human and human-to-human transmission is unknown. We use mathematical modeling to address this. First, we identified Lassa fever outbreaks known to be due to human-to-human chains of transmission. Then, we looked at people hospitalized with the disease in Kenema Government Hospital, Sierra Leone (KGH), who could have been infected either by rodents or humans. We asked, what should the proportion of patients be who get infected by humans, assuming the statistical patterns observed in the human-to-human chains are the same in both instances? We found that around <inline-formula><inline-graphic xlink:href="pntd.0003398.e005.jpg"/></inline-formula> of patients with Lassa fever in KGH probably acquired the disease from another person. In addition, the patterns of disease in people suggest that these <inline-formula><inline-graphic xlink:href="pntd.0003398.e006.jpg"/></inline-formula> of cases are probably initiated by only a small number of infected people (who could be thought of as super-spreaders).</p></abstract><funding-group><funding-statement>This work for the Dynamic Drivers of Disease in Africa Consortium, NERC project no. NE-J001570-1, was funded with support from the Ecosystem Services for Poverty Alleviation (ESPA) programme. The ESPA programme is funded by the Department for International Development (DFID), the Economic and Social Research Council (ESRC) and the Natural Environment Research Council (NERC). See more at: <ext-link ext-link-type="uri" xlink:href="http://www.espa.ac.uk/about/identity/acknowledging-espa-funding#sthash.UivKPObf.dpuf">http://www.espa.ac.uk/about/identity/acknowledging-espa-funding#sthash.UivKPObf.dpuf</ext-link>. GL, JLNW, AAC, CTW and EFC also benefit from the support of the small mammal disease working group, funded by the Research and Policy for Infectious Disease Dynamics (RAPIDD) programme of the Science and Technology Directorate, Department of Homeland Security, and Fogarty International Center, USA. JLNW and AC were also supported by the European Union FP7 project ANTIGONE (contract number 278976). AAC is supported by a Royal Society Wolfson Reearch Merit Award. JLNW is also supported by the Alborada Trust. JSS, LM, RG, and JGS were supported by the US National Institute of Health (JSS: NIH grant P20GM103501; LM, RG, JGS: NIH grant BAA-NIAID-DAIT-NIHQI2008031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="13"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files. In more detail: Data for nosocomial and extra-nosocomial outbreaks are directly available from the following publications: 1) Carey D, Kemp G, White H, Pinneo L, Addy R, et al. (1972) Lassa fever Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 66: 402&#x02013;408. 2) Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, et al. (1973) A hospital epidemic of Lassa fever in Zorzor, Liberia, March&#x02013;April 1972. The American journal of tropical medicine and hygiene 22: 773&#x02013;9. Data for hospital admission to Kenema Governament Hospital (based on: Shaffer JG et al. (2014) Lassa Fever in post-conflict Sierra Leone. PLoS neglected tropical diseases 8: e2748, whose corresponding author may be contacted at <email>jshaffer@tulane.edu</email>) are provided in <xref ref-type="supplementary-material" rid="pntd.0003398.s003">S1 Data</xref>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The authors confirm that all data underlying the findings are fully available without restriction. All relevant data are within the paper and its Supporting Information files. In more detail: Data for nosocomial and extra-nosocomial outbreaks are directly available from the following publications: 1) Carey D, Kemp G, White H, Pinneo L, Addy R, et al. (1972) Lassa fever Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 66: 402&#x02013;408. 2) Monath TP, Mertens PE, Patton R, Moser CR, Baum JJ, et al. (1973) A hospital epidemic of Lassa fever in Zorzor, Liberia, March&#x02013;April 1972. The American journal of tropical medicine and hygiene 22: 773&#x02013;9. Data for hospital admission to Kenema Governament Hospital (based on: Shaffer JG et al. (2014) Lassa Fever in post-conflict Sierra Leone. PLoS neglected tropical diseases 8: e2748, whose corresponding author may be contacted at <email>jshaffer@tulane.edu</email>) are provided in <xref ref-type="supplementary-material" rid="pntd.0003398.s003">S1 Data</xref>.</p></notes></front><body><sec id="s1"><title>Introduction</title><p>Diseases at the animal-human interface are in general subjected to different modes of cross-species transmission: animal-to-animal, animal-to-human, human-to-human and even human-to-animal. Estimating the relative contribution of each is of fundamental importance for the planning and implementation of appropriate infection control and preventive measures. This can be an extremely difficult task if humans and animals share the same physical space, and/or if experimentation (<italic>e.g.</italic> to quantify the probability of animal-to-animal transmission) is subjected to serious limitations. This is the case of Lassa fever (LF), a rodent-borne disease endemic in West Africa. Despite its clear zoonotic origin, there are strong arguments, listed below, to hypothesize that a significant proportion of the burden of LF in humans arises from human-to-human transmission. The aim of this work is to test whether or not patterns in the epidemic curve describing the cases of LF observed in Sierra Leone <xref rid="pntd.0003398-Shaffer1" ref-type="bibr">[1]</xref>, are compatible with patterns observed in chains of pure human-to-human transmission recorded in nosocomial and extra-nosocomial outbreaks <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref>.</p><p>Lassa fever is an acute, viral hemorrhagic disease caused by Lassa fever virus (LASV), an enveloped RNA virus of the Arenaviridae. The disease was first recognized in the village of Lassa, Nigeria in 1969, which caused the death of two missionary-nurses and the grave illness of a third <xref rid="pntd.0003398-Frame1" ref-type="bibr">[4]</xref>. However, cases consistent with LF from the eastern part of Sierra Leone can be traced back to <inline-formula><inline-graphic xlink:href="pntd.0003398.e007.jpg"/></inline-formula>
<xref rid="pntd.0003398-Rose1" ref-type="bibr">[5]</xref>. Since the identification of LASV, human-to-human transmission has been documented in several nosocomial outbreaks (<italic>e.g.</italic>
<xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref> and also <xref rid="pntd.0003398-FichetCalvet1" ref-type="bibr">[6]</xref> for a review), leading to an initial perception that the virus was both highly contagious and virulent <xref rid="pntd.0003398-Frame1" ref-type="bibr">[4]</xref>; this resulted in stringent requirements for containment of the patients <xref rid="pntd.0003398-Cooper1" ref-type="bibr">[7]</xref>. Soon after, its zoonotic origin was recognized and <italic>Mastomys natalensis</italic>, one of the most common African rodents, was identified as the reservoir of the virus <xref rid="pntd.0003398-Monath2" ref-type="bibr">[8]</xref>. The risk of nosocomial transmission was shown to be dramatically reduced by using simple barrier nursing method <xref rid="pntd.0003398-Cooper1" ref-type="bibr">[7]</xref>, <xref rid="pntd.0003398-FisherHoch1" ref-type="bibr">[9]</xref>&#x02013;<xref rid="pntd.0003398-Holmes1" ref-type="bibr">[11]</xref>, suggesting that the risk of human-to-human transmission might be negligible.</p><p>These findings support an apparent, modern-day consensus that in the epidemiology of the disease, human-to-human transmission plays a less important role compared to zoonotic transmission. Accordingly, it has been suggested that patients with LF in non-endemic countries should not be confined to biosafety level 4 containment <xref rid="pntd.0003398-Helmick1" ref-type="bibr">[10]</xref>, and patient containment guidelines issued by the Centers for Disease Control (CDC) and the UK Department of Health and Social Security, in the past have been amended to be less restrictive (see <xref rid="pntd.0003398-Holmes1" ref-type="bibr">[11]</xref>, <xref rid="pntd.0003398-Banatvala1" ref-type="bibr">[12]</xref>, also <xref rid="pntd.0003398-Advisory1" ref-type="bibr">[13]</xref> and its previous versions).</p><p>This narrative concerning the relative importance of human-to-human transmission for LASV, however, requires re-evaluation as there are important indications of human-to-human transmission. More precisely, one of the early nosocomial outbreaks, in Jos, Nigeria (see <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref ref-type="fig" rid="pntd-0003398-g001">Fig. 1</xref> and also the Supporting Information, <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>) was triggered by an index case that transmitted to possibly <inline-formula><inline-graphic xlink:href="pntd.0003398.e008.jpg"/></inline-formula> others in the hospital, with no indication of iatrogenic transfer. Further cases of extra-hospital transmission within a single family (five from the same family, <inline-formula><inline-graphic xlink:href="pntd.0003398.e009.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e010.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e011.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e012.jpg"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="pntd.0003398.e013.jpg"/></inline-formula> who likely initiated the chain) were reported, here and throughout we refer to this chain as an &#x02018;extra-nosocomial&#x02019; chain. Haas <italic>et al.</italic>
<xref rid="pntd.0003398-Haas1" ref-type="bibr">[14]</xref> investigated secondary transmission after an imported case of LF into Europe and found that one of <inline-formula><inline-graphic xlink:href="pntd.0003398.e014.jpg"/></inline-formula> contacts that were tested serologically, a physician who examined the patient on day <inline-formula><inline-graphic xlink:href="pntd.0003398.e015.jpg"/></inline-formula> of illness, had become infected. The authors concluded that, during the initial phase of symptomatic LF the risk of transmission is low, but it may increase with progression of disease and increasing viral excretion. Emond <italic>et al.</italic>
<xref rid="pntd.0003398-Emond1" ref-type="bibr">[15]</xref> described a case of LF in the UK in which the virus was isolated from urine <inline-formula><inline-graphic xlink:href="pntd.0003398.e016.jpg"/></inline-formula> days after the acute phase had ended, despite not being detected earlier. The virus may also be found in pharyngeal secretions for <inline-formula><inline-graphic xlink:href="pntd.0003398.e017.jpg"/></inline-formula> weeks after the onset of clinical signs <xref rid="pntd.0003398-Monath3" ref-type="bibr">[16]</xref>. In an experimental model, Stephenson <italic>et al.</italic>
<xref rid="pntd.0003398-Stephenson1" ref-type="bibr">[17]</xref> showed the ability to infect guinea pigs and cynomolgus monkeys with LASV via the respiratory route and Peters <italic>et al.</italic>
<xref rid="pntd.0003398-Peters1" ref-type="bibr">[18]</xref> demonstrated fatal LASV transmission to monkeys through being held in the same room for <inline-formula><inline-graphic xlink:href="pntd.0003398.e018.jpg"/></inline-formula> days with inoculated rodents. Sagripanti <italic>et al.</italic>
<xref rid="pntd.0003398-Sagripanti1" ref-type="bibr">[19]</xref>, in a dark room at ambient laboratory temperatures controlled between <inline-formula><inline-graphic xlink:href="pntd.0003398.e019.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e020.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e021.jpg"/></inline-formula> relative humidity, showed that the time required for a <inline-formula><inline-graphic xlink:href="pntd.0003398.e022.jpg"/></inline-formula> reduction in viral load of LASV in glass containers was <inline-formula><inline-graphic xlink:href="pntd.0003398.e023.jpg"/></inline-formula> hours and was <inline-formula><inline-graphic xlink:href="pntd.0003398.e024.jpg"/></inline-formula> days for a <inline-formula><inline-graphic xlink:href="pntd.0003398.e025.jpg"/></inline-formula> relative humidity. Also, Kern&#x000e9;is <italic>et al.</italic>
<xref rid="pntd.0003398-Kernis1" ref-type="bibr">[20]</xref> identified that risk factors for positive seroconversion to LASV included either having received a medical injection, or having lived with someone displaying a haemorrhage, in the previous twelve months. No factors related to contact with rodents were identified. Similarly, McCormick <italic>et al.</italic>
<xref rid="pntd.0003398-McCormick1" ref-type="bibr">[21]</xref> reported a lack of correlation between human LASV-specific IgG prevalence and either the level of domestic infestation by <italic>Mastomys</italic>, or the presence of LASV infection in <italic>Mastomys</italic>. These observations, taken together, suggest that a significant (if perhaps variable) proportion of the burden of LF might be associated with human-to-human transmission.</p><fig id="pntd-0003398-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0003398.g001</object-id><label>Figure 1</label><caption><title>Nosocomial outbreaks.</title><p>A: Diagrammatic representation of LF cases admitted at Jos Hospital, Nigeria (total duration of the outbreak <inline-formula><inline-graphic xlink:href="pntd.0003398.e026.jpg"/></inline-formula> days), showing period of illness and interrelation among patients <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>. The horizontal bars represent each patient. The x-axis is the time expressed in days from the start of the outbreak, when TS developed the illness (thus time <inline-formula><inline-graphic xlink:href="pntd.0003398.e027.jpg"/></inline-formula> in the calculation corresponds to <inline-formula><inline-graphic xlink:href="pntd.0003398.e028.jpg"/></inline-formula> December 1969). The grey portion of the bars are the period between the onset of the symptoms and admission to hospital; the black portion of the bars are the period between admission to hospital and discharge/death of the patients; the red thin lines are the period of exposure to the index case TS. The green bar represent the time when the patient was at the ward for unrelated illness. Note, the same diagram in <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref> present an extra case, JT, which is not included here. This case refers to Dr. Jeanette M. Troup one of the first scientists working on Lassa Fever Virus, who contracted the disease from an autopsy accident incurred during examination of one of the fatal cases. B: Diagrammatic representation of LF cases admitted at Zorzor Hospital (total duration of the outbreak <inline-formula><inline-graphic xlink:href="pntd.0003398.e029.jpg"/></inline-formula> days), Liberia, showing period of illness and interrelation among patients <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref>. C: As in <xref ref-type="fig" rid="pntd-0003398-g001">Fig. 1.A</xref>, but the periods of illness (symptoms plus time at hospital) are randomly permuted. The contact network is kept the same. D: An example of how the time <inline-formula><inline-graphic xlink:href="pntd.0003398.e030.jpg"/></inline-formula> was calculated. In this particular case <inline-formula><inline-graphic xlink:href="pntd.0003398.e031.jpg"/></inline-formula> if <inline-formula><inline-graphic xlink:href="pntd.0003398.e032.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e033.jpg"/></inline-formula> otherwise, where <inline-formula><inline-graphic xlink:href="pntd.0003398.e034.jpg"/></inline-formula> is the time when case <inline-formula><inline-graphic xlink:href="pntd.0003398.e035.jpg"/></inline-formula> is no longer exposed to case <inline-formula><inline-graphic xlink:href="pntd.0003398.e036.jpg"/></inline-formula>.</p></caption><graphic xlink:href="pntd.0003398.g001"/></fig><p>Estimating the contribution of human-to-human transmission of LASV and related patterns of transmission (<italic>e.g.</italic> existence of super-spreaders) is of fundamental importance when considering risk assessment and control of LF and related diseases such as the one caused by the arenavirus, Lujo virus <xref rid="pntd.0003398-Briese1" ref-type="bibr">[22]</xref>, not least because LF is one of the more common haemorrhagic fevers exported from endemic areas <xref rid="pntd.0003398-Crowcroft1" ref-type="bibr">[23]</xref>&#x02013;<xref rid="pntd.0003398-Beeching1" ref-type="bibr">[28]</xref>. In addition, perceiving LF as essentially a zoonotic disease only acquired from rodents with little or no infection arising from human beings, may have prevented investigations of the role, if any, of human-to-rodent transmission (i.e. spillback) in the epidemiology of LF.</p><p>Understanding routes of transmission and the proportion of LF cases resulting from human-to-human transmission is critical for developing and prioritizing effective prevention and control interventions, especially in the presence of large variation among subjects in their capability of infecting. The current Ebola outbreak has emphasised further the need for targeted biosecure measures which distinguish managing hemorrhagic fever cases and outbreaks from preventing spillover from reservoirs. This issue has not previously been fully addressed for Lassa Fever. Traditional approaches, such as cluster analysis, to distinguish human-to-human transmission from pure zoonotic transmission cannot be employed here due to the potential of clustering of infection in households from common exposure to infected rodents in addition to clustering arising from infected people. We overcome this problem by adapting other approaches <xref rid="pntd.0003398-Wallinga1" ref-type="bibr">[29]</xref>, <xref rid="pntd.0003398-Obadia1" ref-type="bibr">[30]</xref>, and using data from nosocomial and extra-nosocomial outbreaks and hospitalized patients in Kenema Governmental Hospital (KGH), Sierra Leone <xref rid="pntd.0003398-Shaffer1" ref-type="bibr">[1]</xref>. We use these data to provide an estimation of the contribution of human-to-human transmission to the Lassa fever occurrence in endemic areas and to provide a more-robust assessment of the risk of secondary spread from index cases.</p></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Ethics statement</title><p>The Tulane University Institutional Review Board and the Sierra Leone Ethics Committee approved the research <xref rid="pntd.0003398-Shaffer1" ref-type="bibr">[1]</xref>. Patients either approached KGH directly or were referred to the KGH Lassa Ward from regional health centers or the hospital's general ward on the basis of suspicion of LF. All adult subjects provided written informed consent for the analysis and publication of anonymized laboratory and clinical data. A parent or guardian of any child participant provided written informed consent on their behalf. All data were anonymized prior to analysis.</p></sec><sec id="s2b"><title>Structure and rationale of the modeling approach</title><list list-type="bullet"><list-item><p>Carey, Monath and co-workers <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref> provided evidence of nosocomial and extra-nosocomial chains that are examples of human-to-human transmission of LASV. Based on these early works<xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref> and on the arguments listed in the introduction, it is reasonable to hypothesize that a proportion <inline-formula><inline-graphic xlink:href="pntd.0003398.e037.jpg"/></inline-formula> of hospitalized patients in KGH (<xref ref-type="fig" rid="pntd-0003398-g002">Fig. 2</xref>) contracted the disease from a human source (see section &#x0201c;Available data and evidence of human-to-human transmission&#x0201d;).</p></list-item><list-item><p>The next step was to estimate this proportion <inline-formula><inline-graphic xlink:href="pntd.0003398.e038.jpg"/></inline-formula> ensuring that aspects of (<italic>e.g.</italic> the effective reproduction number) the epidemic curve from KGH are compatible with those in the observed chains <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref>.</p></list-item><list-item><p>To this end, we employed and re-adapted the method of Wallinga and Teunis <xref rid="pntd.0003398-Wallinga1" ref-type="bibr">[29]</xref>, who developed a method to calculate the effective reproduction number (which takes into account depletion of susceptibles) for an epidemic curve. If the network of transmission is known, no further information is required (see section &#x0201c;The effective reproduction number in the nosocomial and extra-nosocomial outbreaks&#x0201d;). Otherwise the distribution of the generation time, <italic>i.e.</italic> the time between a primary case and a secondary case, needs to be ascertained (see section &#x0201c;The effective reproduction number for cases of hospitalised patients in KGH&#x0201d;).</p></list-item><list-item><p>An important feature of the approach of <xref rid="pntd.0003398-Wallinga1" ref-type="bibr">[29]</xref> is the option to consider a fraction of cases in the curve as externally imported, <italic>i.e.</italic> people being infected outside the community. In the context of hospitalized patients in KGH, the cases from animal-to-human transmission are interpreted as externally imported cases, whose proportion is <inline-formula><inline-graphic xlink:href="pntd.0003398.e039.jpg"/></inline-formula>. As we don't know which cases arises from zoonotic or human origin, we randomly selected a fraction <inline-formula><inline-graphic xlink:href="pntd.0003398.e040.jpg"/></inline-formula> of the number of hospitalized patients at the Lassa ward and considered this subset of the epidemic curve as a pure human-to-human chain of transmission. This random sampling was repeated many times to ensure the findings are based on a reliable statistics.</p></list-item><list-item><p>We calculated i) a daily mean effective reproduction numbers, <inline-formula><inline-graphic xlink:href="pntd.0003398.e041.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e042.jpg"/></inline-formula> (definition below and in the glossary in <xref ref-type="supplementary-material" rid="pntd.0003398.s001">S1 Text</xref>), associated with the nosocomial and extra-nosocomial chains of pure human-to-human transmission <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref> as well as the corresponding distributions of the generation times; ii) based on these distributions of the generation times we then estimated a daily mean effective reproduction numbers, <inline-formula><inline-graphic xlink:href="pntd.0003398.e043.jpg"/></inline-formula>, associated to each subset, consisting of a fraction <inline-formula><inline-graphic xlink:href="pntd.0003398.e044.jpg"/></inline-formula> of patients, of the epidemic curve from KGH; iii) finally, by imposing equality of the two reproduction numbers: either <inline-formula><inline-graphic xlink:href="pntd.0003398.e045.jpg"/></inline-formula> or <inline-formula><inline-graphic xlink:href="pntd.0003398.e046.jpg"/></inline-formula>, we estimated the proportion of cases arising from human-to-human transmission, <inline-formula><inline-graphic xlink:href="pntd.0003398.e047.jpg"/></inline-formula>.</p></list-item></list><fig id="pntd-0003398-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0003398.g002</object-id><label>Figure 2</label><caption><title>Epidemic curve.</title><p>Daily number of referred/visiting patients at KGH (confirmed cases only) from the <inline-formula><inline-graphic xlink:href="pntd.0003398.e048.jpg"/></inline-formula> of April <inline-formula><inline-graphic xlink:href="pntd.0003398.e049.jpg"/></inline-formula> to the <inline-formula><inline-graphic xlink:href="pntd.0003398.e050.jpg"/></inline-formula> of January <inline-formula><inline-graphic xlink:href="pntd.0003398.e051.jpg"/></inline-formula>, <xref rid="pntd.0003398-Shaffer1" ref-type="bibr">[1]</xref>.</p></caption><graphic xlink:href="pntd.0003398.g002"/></fig><sec id="s2b1"><title>Appropriateness of comparing data from Sierra Leone with the Jos/Zorzor outbreaks</title><p>Like Kenema in Sierra Leone, Jos and Zorzor are at the heart of the Nigerian and Liberian endemic areas of LF occurrence and, as in Sierra Leone, it is assumed that LASV has been circulating in these areas historically <xref rid="pntd.0003398-Rose1" ref-type="bibr">[5]</xref>, <xref rid="pntd.0003398-Allan1" ref-type="bibr">[31]</xref>, <xref rid="pntd.0003398-McCormick2" ref-type="bibr">[32]</xref>. This is supported by molecular evidence that the Nigerian LASV strain is ancestral to the Sierra Leonean one <xref rid="pntd.0003398-Bowen1" ref-type="bibr">[33]</xref>. In addition, although studies in human prevalence of antibodies to LASV exhibit variation amongst regions (<italic>e.g.</italic> low values in coastal areas), in general human seroprevalence appears to be similar in Nigeria and in the Mano River region (Guinea, Sierra Leone, Liberia) <xref rid="pntd.0003398-Kernis1" ref-type="bibr">[20]</xref>, <xref rid="pntd.0003398-YalleyOgunro1" ref-type="bibr">[34]</xref>&#x02013;<xref rid="pntd.0003398-Klempa1" ref-type="bibr">[40]</xref>.</p><p>Furthermore in recent decades, infection control has focused essentially in minimizing nosocomial transmission, albeit with partial success <xref rid="pntd.0003398-FisherHoch2" ref-type="bibr">[41]</xref>&#x02013;<xref rid="pntd.0003398-FisherHoch3" ref-type="bibr">[43]</xref>. In particular, a study by Tobin <italic>et al.</italic>
<xref rid="pntd.0003398-Tobin1" ref-type="bibr">[42]</xref> revealed a general lack of knowledge of barrier nursing among health workers in rural areas. This problem is expected to be even more persistent among non-professionals, suggesting that control measures have not significantly changed since LF was discovered. Hence despite these data sets being collected at quite different points in time, health-care practices have not changed meaningfully over this time period.</p><p>Finally, the Jos/Zorzor outbreaks were exceptionally severe disease outbreaks, therefore by analyzing only hospitalized patients in KGH, we ensured that we are comparing equivalent situations.</p><p>These considerations justify the choice of comparing the data from KGH with the extra-nosocomial outbreak that occurred in Jos, while the appropriateness of comparing the KGH data with the nosocomial cases in the Jos outbreak is one of the hypothesis being tested in the current work.</p></sec><sec id="s2b2"><title>Available data and evidence of human-to-human transmission</title><p>We analyzed the data from two nosocomial LF outbreaks: Jos, Nigeria in 1970 (<inline-formula><inline-graphic xlink:href="pntd.0003398.e052.jpg"/></inline-formula> cases) <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref> and Zorzor, Liberia in 1972 (<inline-formula><inline-graphic xlink:href="pntd.0003398.e053.jpg"/></inline-formula> cases) <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref>. In the Jos outbreak, extra hospital infections with no contact with the index case were observed (a single family <inline-formula><inline-graphic xlink:href="pntd.0003398.e054.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e055.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e056.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e057.jpg"/></inline-formula>, and <inline-formula><inline-graphic xlink:href="pntd.0003398.e058.jpg"/></inline-formula> with the three children <inline-formula><inline-graphic xlink:href="pntd.0003398.e059.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e060.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e061.jpg"/></inline-formula> who never visited the ward). These appear to be human-to-human chains; sampling and testing of rodents near the homes of LF patients in Jos, as well as in the larger geographic area, showed no evidence of LASV in rodents <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, further supporting human-to-human transmission maintaining these epidemics. Further details of the two outbreaks and the full networks of contacts are presented in the Supporting Information, <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>.</p><p>In contrast with many emerging zoonoses, the reported incidence of LF in people is high in endemic areas, as reflected in data from KGH in Sierra Leone <xref rid="pntd.0003398-Shaffer1" ref-type="bibr">[1]</xref> (<xref ref-type="fig" rid="pntd-0003398-g002">Fig. 2</xref>), thus allowing a more robust analysis of the transmission dynamics. KGH is the only health facility in Sierra Leone where people can be diagnosed and treated for suspected LF. The hospital facilities include an isolation ward specifically for LF patients with a highly trained clinical staff equipped with appropriate personal protective equipment. KGH records provide hospitalized patient data (day of admission, day of discharge, etc.) for suspected and confirmed cases of LF, divided by age, gender, ethnic group, location and other factors <xref rid="pntd.0003398-Shaffer1" ref-type="bibr">[1]</xref>.</p><p>We used data abstracted from patient medical charts and LF diagnostic tests for <inline-formula><inline-graphic xlink:href="pntd.0003398.e062.jpg"/></inline-formula> suspected Lassa cases presenting to the KGH Lassa Ward from <inline-formula><inline-graphic xlink:href="pntd.0003398.e063.jpg"/></inline-formula> of April <inline-formula><inline-graphic xlink:href="pntd.0003398.e064.jpg"/></inline-formula> to the <inline-formula><inline-graphic xlink:href="pntd.0003398.e065.jpg"/></inline-formula> of January <inline-formula><inline-graphic xlink:href="pntd.0003398.e066.jpg"/></inline-formula>. Among these subjects, <inline-formula><inline-graphic xlink:href="pntd.0003398.e067.jpg"/></inline-formula> (<xref ref-type="fig" rid="pntd-0003398-g002">Fig. 2</xref>) were confirmed as LF cases, <italic>i.e.</italic> either subjects with acute infection (tested positive LF using an antigen-based ELISA approach) or with recent LF (tested positive to IgM antibodies) <xref rid="pntd.0003398-Shaffer1" ref-type="bibr">[1]</xref>. These data correspond to the most accurate and complete set of patient records available at KGH. April <inline-formula><inline-graphic xlink:href="pntd.0003398.e068.jpg"/></inline-formula> was chosen as the lower endpoint for our study sample due to significant improvements in data quality. These improvements are largely attributed to several NIH-funded research projects to develop and improve the diagnostic tests for LF. Improvements in clinical data quality can be attributed to more comprehensive questionnaire forms and increased community outreach and surveillance activities.</p></sec><sec id="s2b3"><title>The effective reproduction number in the nosocomial and extra-nosocomial outbreaks</title><p>We calculated the effective reproduction number based on the observed dates of onset of symptoms, start and duration of exposure to the index cases and start and duration of exposure to all other cases. This information was directly obtained from the literature <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref>, which provided detailed descriptions of the network of contacts (<xref ref-type="fig" rid="pntd-0003398-g001">Fig. 1</xref> and S1 table in <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>). Inspired by the work of Wallinga and Teunis <xref rid="pntd.0003398-Wallinga1" ref-type="bibr">[29]</xref>, the relative likelihood <inline-formula><inline-graphic xlink:href="pntd.0003398.e069.jpg"/></inline-formula> that case <inline-formula><inline-graphic xlink:href="pntd.0003398.e070.jpg"/></inline-formula> has been infected by case <inline-formula><inline-graphic xlink:href="pntd.0003398.e071.jpg"/></inline-formula> was calculated as:<disp-formula id="pntd.0003398.e072"><graphic xlink:href="pntd.0003398.e072.jpg" position="anchor" orientation="portrait"/><label>(1)</label></disp-formula>here <inline-formula><inline-graphic xlink:href="pntd.0003398.e073.jpg"/></inline-formula> is the time of exposure of case <inline-formula><inline-graphic xlink:href="pntd.0003398.e074.jpg"/></inline-formula> to case <inline-formula><inline-graphic xlink:href="pntd.0003398.e075.jpg"/></inline-formula> while case <inline-formula><inline-graphic xlink:href="pntd.0003398.e076.jpg"/></inline-formula> is infectious, <italic>i.e.</italic> the interval <inline-formula><inline-graphic xlink:href="pntd.0003398.e077.jpg"/></inline-formula> is given by the intersection <inline-formula><inline-graphic xlink:href="pntd.0003398.e078.jpg"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="pntd.0003398.e079.jpg"/></inline-formula> is the infectious period of case <inline-formula><inline-graphic xlink:href="pntd.0003398.e080.jpg"/></inline-formula>, calculated as the difference between the time <inline-formula><inline-graphic xlink:href="pntd.0003398.e081.jpg"/></inline-formula>, when the symptoms end (either because the patient recovers or dies) and the time <inline-formula><inline-graphic xlink:href="pntd.0003398.e082.jpg"/></inline-formula>, when the symptoms begin; <inline-formula><inline-graphic xlink:href="pntd.0003398.e083.jpg"/></inline-formula> is the duration of exposure of case <inline-formula><inline-graphic xlink:href="pntd.0003398.e084.jpg"/></inline-formula> to case <inline-formula><inline-graphic xlink:href="pntd.0003398.e085.jpg"/></inline-formula> provided by the literature <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref>. It is important to note that <inline-formula><inline-graphic xlink:href="pntd.0003398.e086.jpg"/></inline-formula>, and thus <inline-formula><inline-graphic xlink:href="pntd.0003398.e087.jpg"/></inline-formula>, is explicitly time-dependent, (<xref ref-type="fig" rid="pntd-0003398-g001">Fig. 1.D</xref>). The index <inline-formula><inline-graphic xlink:href="pntd.0003398.e088.jpg"/></inline-formula> represents all possible cases within a nosocomial outbreak. Important underlying assumptions are: each event can independently start a new chain of human-to-human transmission, beginning of infectiousness coincides with the onset of symptoms, and infections occur with equal probability at any time during the interval <inline-formula><inline-graphic xlink:href="pntd.0003398.e089.jpg"/></inline-formula>. Accordingly, the sum <inline-formula><inline-graphic xlink:href="pntd.0003398.e090.jpg"/></inline-formula> over all cases <inline-formula><inline-graphic xlink:href="pntd.0003398.e091.jpg"/></inline-formula>, represents the <italic>individual</italic> effective reproduction number for case <inline-formula><inline-graphic xlink:href="pntd.0003398.e092.jpg"/></inline-formula> at the time <inline-formula><inline-graphic xlink:href="pntd.0003398.e093.jpg"/></inline-formula> when the case arises. If multiple cases are observed at the same time <inline-formula><inline-graphic xlink:href="pntd.0003398.e094.jpg"/></inline-formula>, then <inline-formula><inline-graphic xlink:href="pntd.0003398.e095.jpg"/></inline-formula> is averaged appropriately. To increase the sample size and improve the estimation, the duration of the symptoms of LF and the period spent at the hospital associated with each patient were randomly rearranged among the <inline-formula><inline-graphic xlink:href="pntd.0003398.e096.jpg"/></inline-formula> cases (<xref ref-type="fig" rid="pntd-0003398-g001">Fig. 1.C</xref>), then the <italic>ensemble</italic> average individual effective reproduction number was calculated based on <inline-formula><inline-graphic xlink:href="pntd.0003398.e097.jpg"/></inline-formula> of these permutations. The network of contacts was kept the same. The identical approach was used to calculate the effective reproduction number, <inline-formula><inline-graphic xlink:href="pntd.0003398.e098.jpg"/></inline-formula>, for the extra-nosocomial situation, with the network of contacts restricted to the family <inline-formula><inline-graphic xlink:href="pntd.0003398.e099.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e100.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e101.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e102.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e103.jpg"/></inline-formula> who presumably initiated the chain. We use the notation <inline-formula><inline-graphic xlink:href="pntd.0003398.e104.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e105.jpg"/></inline-formula> to indicate the set of all individual effective reproduction numbers for the nosocomial and extra-nosocomial cases respectively, while the total effective reproduction numbers <inline-formula><inline-graphic xlink:href="pntd.0003398.e106.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e107.jpg"/></inline-formula> represent the corresponding average number of cases during the entire outbreak, <italic>i.e.</italic>
<inline-formula><inline-graphic xlink:href="pntd.0003398.e108.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e109.jpg"/></inline-formula> respectively. To adjust for the different duration expected in different outbreaks, we calculate a <italic>daily mean</italic> effective reproduction number as <inline-formula><inline-graphic xlink:href="pntd.0003398.e110.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e111.jpg"/></inline-formula> where <inline-formula><inline-graphic xlink:href="pntd.0003398.e112.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e113.jpg"/></inline-formula> are the typical duration of the nosocomial and extra-nosocomial outbreaks.</p><p>The correctness of the approach was corroborated by performing the same analysis but by imposing that each case is exposed only to the index case. For the situation in Jos, the individual reproduction numbers were zero for all cases except for <inline-formula><inline-graphic xlink:href="pntd.0003398.e114.jpg"/></inline-formula> which results in <inline-formula><inline-graphic xlink:href="pntd.0003398.e115.jpg"/></inline-formula>, <italic>i.e.</italic> the only cases exposed to <inline-formula><inline-graphic xlink:href="pntd.0003398.e116.jpg"/></inline-formula> and marked with a thin red line in <xref ref-type="fig" rid="pntd-0003398-g001">Fig. 1</xref>.</p><p>The distribution of the quantity <inline-formula><inline-graphic xlink:href="pntd.0003398.e117.jpg"/></inline-formula> is interpreted as the distribution of the generation time, <italic>i.e.</italic> the time between a primary case and a secondary case, and it is presented in <xref ref-type="fig" rid="pntd-0003398-g003">Figs. 3.C and 3.D</xref> (see also Figures S2, S3, S4 and S5 in <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>).</p><fig id="pntd-0003398-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0003398.g003</object-id><label>Figure 3</label><caption><title>Individual effective reproduction number and generation time.</title><p>Box-plot for the individual <inline-formula><inline-graphic xlink:href="pntd.0003398.e118.jpg"/></inline-formula> for the nosocomial outbreak described in <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref> based on the <inline-formula><inline-graphic xlink:href="pntd.0003398.e119.jpg"/></inline-formula> permutations of the duration of illness. It shows the first and third percentiles, the minimum and maximum values, the median, and outliers (red dots). The dashed line represents the case when the effective reproduction number is equal to <inline-formula><inline-graphic xlink:href="pntd.0003398.e120.jpg"/></inline-formula>. A: nosocomial outbreak in Jos <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>. B: nosocomial outbreak in Zorzor <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref>. C: Distribution of generation time for the two nosocomial outbreaks. The statistics are based on the <inline-formula><inline-graphic xlink:href="pntd.0003398.e121.jpg"/></inline-formula> permutations of the duration of illness. D: Distribution of generation time for extra-nosocomial cases. The statistics are based on the <inline-formula><inline-graphic xlink:href="pntd.0003398.e122.jpg"/></inline-formula> permutations of the duration of illness.</p></caption><graphic xlink:href="pntd.0003398.g003"/></fig></sec><sec id="s2b4"><title>The effective reproduction number for cases of hospitalised patients in KGH</title><p>Following the approach of Wallinga and Teunis (see <xref rid="pntd.0003398-Wallinga1" ref-type="bibr">[29]</xref>, <xref rid="pntd.0003398-Obadia1" ref-type="bibr">[30]</xref> and their appendix for validation of the procedure), the relative likelihood that case <inline-formula><inline-graphic xlink:href="pntd.0003398.e123.jpg"/></inline-formula> has been infected by case <inline-formula><inline-graphic xlink:href="pntd.0003398.e124.jpg"/></inline-formula>, given their difference in time of symptom onset <inline-formula><inline-graphic xlink:href="pntd.0003398.e125.jpg"/></inline-formula>, approximated here as the difference in time of admission to hospital, is then the likelihood that case <inline-formula><inline-graphic xlink:href="pntd.0003398.e126.jpg"/></inline-formula> has been infected by case <inline-formula><inline-graphic xlink:href="pntd.0003398.e127.jpg"/></inline-formula>, normalized by the likelihood that case <inline-formula><inline-graphic xlink:href="pntd.0003398.e128.jpg"/></inline-formula> has been infected by any other case <inline-formula><inline-graphic xlink:href="pntd.0003398.e129.jpg"/></inline-formula>
<disp-formula id="pntd.0003398.e130"><graphic xlink:href="pntd.0003398.e130.jpg" position="anchor" orientation="portrait"/><label>(2)</label></disp-formula>where <inline-formula><inline-graphic xlink:href="pntd.0003398.e131.jpg"/></inline-formula> is the distribution for the generation interval and it is assumed to be the empirical distribution obtained from the nosocomial and extra-nosocomial outbreaks (shown in <xref ref-type="fig" rid="pntd-0003398-g003">Figs. 3.C and 3.D</xref>). The effective reproduction number for case <inline-formula><inline-graphic xlink:href="pntd.0003398.e132.jpg"/></inline-formula> is the sum over all cases <inline-formula><inline-graphic xlink:href="pntd.0003398.e133.jpg"/></inline-formula>, weighted by the relative likelihood that case <inline-formula><inline-graphic xlink:href="pntd.0003398.e134.jpg"/></inline-formula> has been infected by case <inline-formula><inline-graphic xlink:href="pntd.0003398.e135.jpg"/></inline-formula>
<disp-formula id="pntd.0003398.e136"><graphic xlink:href="pntd.0003398.e136.jpg" position="anchor" orientation="portrait"/><label>(3)</label></disp-formula>
</p><p>This quantity depends on the time <inline-formula><inline-graphic xlink:href="pntd.0003398.e137.jpg"/></inline-formula> when case <inline-formula><inline-graphic xlink:href="pntd.0003398.e138.jpg"/></inline-formula> occurs. The set of all <inline-formula><inline-graphic xlink:href="pntd.0003398.e139.jpg"/></inline-formula> cases are obtained by the epidemic curve, describing the daily number of reported cases by date of symptom onset (<xref ref-type="fig" rid="pntd-0003398-g002">Fig. 2</xref>), <inline-formula><inline-graphic xlink:href="pntd.0003398.e140.jpg"/></inline-formula> is the total number of reported cases. Underlying this calculation is the assumption that the spread of the disease occurs through human-to-human transmission only, however, a substantial proportion of cases, <inline-formula><inline-graphic xlink:href="pntd.0003398.e141.jpg"/></inline-formula>, is expected to be due to zoonotic transmission, <italic>i.e.</italic> only through contacts with the rodent population, which can be considered as cases that have contracted infection from outside the population. These, therefore, cannot be regarded as secondary-tertiary etc. cases, although they can initiate a human-to-human chain. Under these circumstances, the effective reproduction number in <xref ref-type="disp-formula" rid="pntd.0003398.e136">equation (3</xref>) must be calculated by removing these <inline-formula><inline-graphic xlink:href="pntd.0003398.e142.jpg"/></inline-formula> imported cases, <italic>i.e.</italic>
<disp-formula id="pntd.0003398.e143"><graphic xlink:href="pntd.0003398.e143.jpg" position="anchor" orientation="portrait"/><label>(4)</label></disp-formula>
</p><p>The set of all individual effective reproduction numbers is indicated by <inline-formula><inline-graphic xlink:href="pntd.0003398.e144.jpg"/></inline-formula>, while <inline-formula><inline-graphic xlink:href="pntd.0003398.e145.jpg"/></inline-formula> is the <italic>total</italic> effective reproduction number, <italic>i.e.</italic>
<inline-formula><inline-graphic xlink:href="pntd.0003398.e146.jpg"/></inline-formula>, where to simplify the notation we dropped the dependency on <inline-formula><inline-graphic xlink:href="pntd.0003398.e147.jpg"/></inline-formula>. This value represents the average number of cases during the entire epidemic compatible with the particular generation time. As above, we averaged to obtain the <italic>daily mean</italic> effective reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e148.jpg"/></inline-formula> where <inline-formula><inline-graphic xlink:href="pntd.0003398.e149.jpg"/></inline-formula> is the duration of the epidemics. The calculations were carried out by using the R package R0, provided by Obadia and co-authors <xref rid="pntd.0003398-Obadia1" ref-type="bibr">[30]</xref>, <xref rid="pntd.0003398-R1" ref-type="bibr">[44]</xref>.</p><p>We compared two published outbreaks to illustrate the likely bounds of human to human transmission. Initially, we assumed that the extent of human-to-human transmission in nosocomial outbreaks in Jos and Zorzor <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref>, <xref rid="pntd.0003398-Monath1" ref-type="bibr">[3]</xref> represent the general situation in an endemic area. Alternatively, we rejected this assumption and considered only the out of hospital human-to-human transmission in Jos (five from the same family, <inline-formula><inline-graphic xlink:href="pntd.0003398.e150.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e151.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e152.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e153.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e154.jpg"/></inline-formula> who initiated the chain), as being representative of the general endemic situation. We estimated the generation number and the mean nosocomial reproduction numbers for these two alternatives. By imposing equality with the mean nosocomial reproduction numbers (either <inline-formula><inline-graphic xlink:href="pntd.0003398.e155.jpg"/></inline-formula> or <inline-formula><inline-graphic xlink:href="pntd.0003398.e156.jpg"/></inline-formula>), we inferred the proportion <inline-formula><inline-graphic xlink:href="pntd.0003398.e157.jpg"/></inline-formula>.</p><p>To allow comparison with the effective reproduction number for the Kenema data, which by definition is based only on outbreaks where the primary case is assumed to be among those reported <xref rid="pntd.0003398-Wallinga1" ref-type="bibr">[29]</xref>, the index patients <inline-formula><inline-graphic xlink:href="pntd.0003398.e158.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e159.jpg"/></inline-formula> from the Jos and Zorzor outbreaks were assumed to be secondary cases to unreported human cases. On the grounds of realism, and also computational economy, the epidemic curve from KGH (<xref ref-type="fig" rid="pntd-0003398-g002">Fig. 2</xref>) is assumed to be a collection of multiple chains of mean duration <inline-formula><inline-graphic xlink:href="pntd.0003398.e160.jpg"/></inline-formula>, rather than a 2-year long un-interrupted epidemic. The starting times of each human-to-human chain were randomly chosen within the <inline-formula><inline-graphic xlink:href="pntd.0003398.e161.jpg"/></inline-formula> year period of the KGH epidemic curve. Similarly, as humans and rodents share the same physical space, cross-species transmission can occur at any time, thus the <inline-formula><inline-graphic xlink:href="pntd.0003398.e162.jpg"/></inline-formula> imported cases were randomly chosen from the network of contacts. For each value of <inline-formula><inline-graphic xlink:href="pntd.0003398.e163.jpg"/></inline-formula>, the ensemble sample of the simulations was <inline-formula><inline-graphic xlink:href="pntd.0003398.e164.jpg"/></inline-formula>.</p></sec></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Effective reproduction number for nosocomial outbreaks</title><p>
<xref ref-type="fig" rid="pntd-0003398-g003">Figs. 3.A and 3.B</xref> show the effective reproduction number for each patient for the two nosocomial outbreaks respectively. As expected, the largest values are associated with the index case <inline-formula><inline-graphic xlink:href="pntd.0003398.e165.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e166.jpg"/></inline-formula> for the Jos and Zorzor outbreaks, respectively. In several cases, however, the effective reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e167.jpg"/></inline-formula>; particularly important is case <inline-formula><inline-graphic xlink:href="pntd.0003398.e168.jpg"/></inline-formula> in the Jos outbreak with an effective reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e169.jpg"/></inline-formula>, who most likely initiated extra-nosocomial transmission in her family.</p></sec><sec id="s3b"><title>Estimating the contribution of human-to-human transmission</title><p>
<xref ref-type="fig" rid="pntd-0003398-g004">Fig. 4</xref> shows the total effective reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e170.jpg"/></inline-formula> and its daily mean <inline-formula><inline-graphic xlink:href="pntd.0003398.e171.jpg"/></inline-formula> for the cases in KGH, <italic>vs</italic> the estimated proportion <inline-formula><inline-graphic xlink:href="pntd.0003398.e172.jpg"/></inline-formula> of cases due to human-to-human transmission. The shaded grey area covers the range between <inline-formula><inline-graphic xlink:href="pntd.0003398.e173.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e174.jpg"/></inline-formula> percentiles arising from the <inline-formula><inline-graphic xlink:href="pntd.0003398.e175.jpg"/></inline-formula> simulations for each value of <inline-formula><inline-graphic xlink:href="pntd.0003398.e176.jpg"/></inline-formula>. The predictions were then compared with the total effective reproduction number (or with the equivalent daily mean), in the nosocomial outbreaks <inline-formula><inline-graphic xlink:href="pntd.0003398.e177.jpg"/></inline-formula> (or <inline-formula><inline-graphic xlink:href="pntd.0003398.e178.jpg"/></inline-formula>) based on the full network of cases and with the extra-nosocomial cases in Jos alone <inline-formula><inline-graphic xlink:href="pntd.0003398.e179.jpg"/></inline-formula> (or <inline-formula><inline-graphic xlink:href="pntd.0003398.e180.jpg"/></inline-formula>). For the full network of cases, the mean nosocomial reproduction number was higher than the mean KGH one, implying that the severe hospital outbreaks ought to be seen as exceptional circumstances. In contrast, the daily mean effective reproduction number arising from the Jos extra-hospital cases (due only to human-to-human transmission) was entirely compatible with the daily mean KGH effective reproduction number if we allow a proportion of cases to be due to human-to-human transmission <inline-formula><inline-graphic xlink:href="pntd.0003398.e181.jpg"/></inline-formula>. Based on the <inline-formula><inline-graphic xlink:href="pntd.0003398.e182.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e183.jpg"/></inline-formula> percentiles in the predictions for the reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e184.jpg"/></inline-formula>, the lower and upper estimates for the proportion of human-to-human transmission are <inline-formula><inline-graphic xlink:href="pntd.0003398.e185.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e186.jpg"/></inline-formula> respectively.</p><fig id="pntd-0003398-g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0003398.g004</object-id><label>Figure 4</label><caption><title>Contribution of human-to-human transmission.</title><p>Mean value of the total effective reproduction number, <inline-formula><inline-graphic xlink:href="pntd.0003398.e187.jpg"/></inline-formula> and its daily mean, <inline-formula><inline-graphic xlink:href="pntd.0003398.e188.jpg"/></inline-formula>, for the KGH epidemic curve <italic>vs</italic> the proportion <inline-formula><inline-graphic xlink:href="pntd.0003398.e189.jpg"/></inline-formula> of cases due to human-to-human transmission (blue line). The shaded grey area covers the range between the <inline-formula><inline-graphic xlink:href="pntd.0003398.e190.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e191.jpg"/></inline-formula> percentiles in <inline-formula><inline-graphic xlink:href="pntd.0003398.e192.jpg"/></inline-formula> and/or <inline-formula><inline-graphic xlink:href="pntd.0003398.e193.jpg"/></inline-formula>; the dashed red line represents the mean, nosocomial, effective reproduction number. A and B: <inline-formula><inline-graphic xlink:href="pntd.0003398.e194.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e195.jpg"/></inline-formula> based on the full networks (in Jos and in Zorzor) of nosocomial cases; <inline-formula><inline-graphic xlink:href="pntd.0003398.e196.jpg"/></inline-formula> days. C and D: <inline-formula><inline-graphic xlink:href="pntd.0003398.e197.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e198.jpg"/></inline-formula> based on the extra-nosocomial cases in Jos; <inline-formula><inline-graphic xlink:href="pntd.0003398.e199.jpg"/></inline-formula> days.</p></caption><graphic xlink:href="pntd.0003398.g004"/></fig></sec><sec id="s3c"><title>Quantifying the impact of the super-spreaders</title><p>Super-spreaders are individuals who can infect a disproportionately large pool of susceptibles <xref rid="pntd.0003398-Stein1" ref-type="bibr">[45]</xref>. Here, super-spreading events are identified and quantified by analyzing how the effective reproduction number is distributed. The distribution of the individual effective reproduction numbers for the Jos and Zorzor outbreaks, based on the <inline-formula><inline-graphic xlink:href="pntd.0003398.e200.jpg"/></inline-formula> permutations of the duration of illness, is shown in <xref ref-type="fig" rid="pntd-0003398-g005">Fig. 5.A</xref>. Although <inline-formula><inline-graphic xlink:href="pntd.0003398.e201.jpg"/></inline-formula> of the predictions for individual <inline-formula><inline-graphic xlink:href="pntd.0003398.e202.jpg"/></inline-formula>, there is a fat tailed distribution, with extreme values of <inline-formula><inline-graphic xlink:href="pntd.0003398.e203.jpg"/></inline-formula>. Similar patterns are observed for KGH cases for the individual effective reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e204.jpg"/></inline-formula>. As shown in <xref ref-type="fig" rid="pntd-0003398-g005">Fig. 5.B and 5.C</xref>, the distribution of the individual and total, effective reproduction numbers, <inline-formula><inline-graphic xlink:href="pntd.0003398.e205.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e206.jpg"/></inline-formula> appears to have a fat-tailed distribution, especially for larger values of <inline-formula><inline-graphic xlink:href="pntd.0003398.e207.jpg"/></inline-formula>.</p><fig id="pntd-0003398-g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0003398.g005</object-id><label>Figure 5</label><caption><title>Impact of super-spreaders I.</title><p>A: Distribution of all individual <inline-formula><inline-graphic xlink:href="pntd.0003398.e208.jpg"/></inline-formula> for both nosocomial outbreaks, based on the <inline-formula><inline-graphic xlink:href="pntd.0003398.e209.jpg"/></inline-formula> permutations of the duration of illness. Mean value of the joint data: <inline-formula><inline-graphic xlink:href="pntd.0003398.e210.jpg"/></inline-formula>, median: <inline-formula><inline-graphic xlink:href="pntd.0003398.e211.jpg"/></inline-formula>, maximum: <inline-formula><inline-graphic xlink:href="pntd.0003398.e212.jpg"/></inline-formula>, proportion of cases when <inline-formula><inline-graphic xlink:href="pntd.0003398.e213.jpg"/></inline-formula>: <inline-formula><inline-graphic xlink:href="pntd.0003398.e214.jpg"/></inline-formula>, proportion of cases when <inline-formula><inline-graphic xlink:href="pntd.0003398.e215.jpg"/></inline-formula>: <inline-formula><inline-graphic xlink:href="pntd.0003398.e216.jpg"/></inline-formula>. B: Distribution of the effective reproduction number for cases of hospitalized patients in KGH for different values of the contribution of human-to-human transmission, <inline-formula><inline-graphic xlink:href="pntd.0003398.e217.jpg"/></inline-formula>, the corresponding data for the extra-nosocomial (<inline-formula><inline-graphic xlink:href="pntd.0003398.e218.jpg"/></inline-formula> permutation based on <inline-formula><inline-graphic xlink:href="pntd.0003398.e219.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e220.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e221.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e222.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e223.jpg"/></inline-formula> cases in Jos) and all nosocomial outbreaks (based on all Jos and Zorzor cases) are also shown. C: Distribution of the total effective reproduction number, <italic>i.e.</italic> the average number of cases during the entire duration of the epidemic for different values the contribution of human-to-human transmission, <inline-formula><inline-graphic xlink:href="pntd.0003398.e224.jpg"/></inline-formula>.</p></caption><graphic xlink:href="pntd.0003398.g005"/></fig><p>A simple approach to evaluate the risk of super-spreaders is to invoke the so-called &#x02018;20/80 rule&#x02019; (whereby <inline-formula><inline-graphic xlink:href="pntd.0003398.e225.jpg"/></inline-formula> of cases cause <inline-formula><inline-graphic xlink:href="pntd.0003398.e226.jpg"/></inline-formula> of transmission, see <xref rid="pntd.0003398-Stein1" ref-type="bibr">[45]</xref>, <xref rid="pntd.0003398-LloydSmith1" ref-type="bibr">[46]</xref>). To this end, for different values of the contribution of human-to-human transmission, <inline-formula><inline-graphic xlink:href="pntd.0003398.e227.jpg"/></inline-formula>, we calculated i) the proportion of cases when <inline-formula><inline-graphic xlink:href="pntd.0003398.e228.jpg"/></inline-formula> (<xref ref-type="fig" rid="pntd-0003398-g006">Fig. 6.A</xref>), and ii) its proportional impact, given by the expected, relative number of secondary cases generated by this proportion (see <xref ref-type="fig" rid="pntd-0003398-g006">Fig. 6.B</xref> for further explanations); the maximum <inline-formula><inline-graphic xlink:href="pntd.0003398.e229.jpg"/></inline-formula> in the simulations was also recorded. For a contribution of human-to-human transmission in the region of <inline-formula><inline-graphic xlink:href="pntd.0003398.e230.jpg"/></inline-formula>, only <inline-formula><inline-graphic xlink:href="pntd.0003398.e231.jpg"/></inline-formula> of realizations gave <inline-formula><inline-graphic xlink:href="pntd.0003398.e232.jpg"/></inline-formula>, but they are, on average, responsible for <inline-formula><inline-graphic xlink:href="pntd.0003398.e233.jpg"/></inline-formula> of secondary cases, with a maximum <inline-formula><inline-graphic xlink:href="pntd.0003398.e234.jpg"/></inline-formula>. In an extreme situation, when the disease is transmitted only by humans, <inline-formula><inline-graphic xlink:href="pntd.0003398.e235.jpg"/></inline-formula> of cases are responsible for the <inline-formula><inline-graphic xlink:href="pntd.0003398.e236.jpg"/></inline-formula> of secondary cases with a maximum <inline-formula><inline-graphic xlink:href="pntd.0003398.e237.jpg"/></inline-formula> up to <inline-formula><inline-graphic xlink:href="pntd.0003398.e238.jpg"/></inline-formula>, which resembles the &#x02018;20/80 rule&#x02019;.</p><fig id="pntd-0003398-g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pntd.0003398.g006</object-id><label>Figure 6</label><caption><title>Impact of super-spreaders II.</title><p>A: proportion of cases when the individual effective reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e239.jpg"/></inline-formula> is greater than one. (<italic>i.e.</italic> the ratio of the cardinalities of <inline-formula><inline-graphic xlink:href="pntd.0003398.e240.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e241.jpg"/></inline-formula>, where <inline-formula><inline-graphic xlink:href="pntd.0003398.e242.jpg"/></inline-formula> is set of all simulated <inline-formula><inline-graphic xlink:href="pntd.0003398.e243.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e244.jpg"/></inline-formula> the subset of cases when <inline-formula><inline-graphic xlink:href="pntd.0003398.e245.jpg"/></inline-formula> is greater than one). B: the expected, relative number of cases generated by this proportion. (<italic>i.e.</italic> the fraction of the areas of <inline-formula><inline-graphic xlink:href="pntd.0003398.e246.jpg"/></inline-formula>)</p></caption><graphic xlink:href="pntd.0003398.g006"/></fig><p>More sophisticated ways to assess the risk of super-spreaders are presented in the <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>. In particular, we fitted the distribution for the individual effective reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e247.jpg"/></inline-formula> from KGH with an exponential and a log-normal distribution. The observed KGH distribution is &#x02018;fatter&#x02019; than the corresponding exponential fit, although not as heavy as the log-normal. Furthermore we fitted two standard discrete distributions, the Poisson, representative of thin-tailed distributions, and the negative-binomial, representative of fat-tailed distributions, with the distribution for the integer part (as we are considering discrete distributions) of <inline-formula><inline-graphic xlink:href="pntd.0003398.e248.jpg"/></inline-formula>, <italic>i.e.</italic> the average number of cases during the entire epidemic. As can be seen, the last distribution is better fitted by a negative-binomial distribution, especially for the tail (S6 Figure in <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>).</p></sec><sec id="s3d"><title>Sensitivity of the predictions</title><sec id="s3d1"><title>Effect of the duration of epidemics</title><p>Different values for the typical duration of a human-to-human chain, <inline-formula><inline-graphic xlink:href="pntd.0003398.e249.jpg"/></inline-formula>, were explored. As expected, the longer the duration, <inline-formula><inline-graphic xlink:href="pntd.0003398.e250.jpg"/></inline-formula>, the larger the availability of susceptibles and the higher the effective reproduction number. However, when the effective reproduction number is rescaled by the duration of the epidemics, <italic>i.e.</italic> the daily mean effective reproduction number <inline-formula><inline-graphic xlink:href="pntd.0003398.e251.jpg"/></inline-formula>, all the predictions are similar. This can be seen by comparing the plots <inline-formula><inline-graphic xlink:href="pntd.0003398.e252.jpg"/></inline-formula> in <xref ref-type="fig" rid="pntd-0003398-g004">Figs. 4.B</xref> (<inline-formula><inline-graphic xlink:href="pntd.0003398.e253.jpg"/></inline-formula> days), 4.D (<inline-formula><inline-graphic xlink:href="pntd.0003398.e254.jpg"/></inline-formula> days) and S1 Figure in <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref> (<inline-formula><inline-graphic xlink:href="pntd.0003398.e255.jpg"/></inline-formula> days).</p><p>Based on this invariance, we can infer the proportion <inline-formula><inline-graphic xlink:href="pntd.0003398.e256.jpg"/></inline-formula>, irrespective of the choice of the mean duration <inline-formula><inline-graphic xlink:href="pntd.0003398.e257.jpg"/></inline-formula>, provided that we know the typical duration of the nosocomial and extra-nosocomial chains <inline-formula><inline-graphic xlink:href="pntd.0003398.e258.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e259.jpg"/></inline-formula>. For the nosocomial case, a reasonable choice is <inline-formula><inline-graphic xlink:href="pntd.0003398.e260.jpg"/></inline-formula> days, which is the average duration of nosocomial outbreaks observed in Jos and Zorzor hospitals (<inline-formula><inline-graphic xlink:href="pntd.0003398.e261.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e262.jpg"/></inline-formula> days respectively, the last days correspond to when the last person developed symptoms). For the extra-nosocomial chains the choice is less clear, as the member of the family were already in contact with the index case <inline-formula><inline-graphic xlink:href="pntd.0003398.e263.jpg"/></inline-formula> before she developed symptoms, and shedding of the virus could happen any time before symptom onset. Therefore we made a conservative choice of <inline-formula><inline-graphic xlink:href="pntd.0003398.e264.jpg"/></inline-formula> days which corresponds to the maximum duration of the Jos outbreak (here the last day corresponds to when case <inline-formula><inline-graphic xlink:href="pntd.0003398.e265.jpg"/></inline-formula> recovered). Any shorter choice of the duration <inline-formula><inline-graphic xlink:href="pntd.0003398.e266.jpg"/></inline-formula>, will result in a larger value of the proportion <inline-formula><inline-graphic xlink:href="pntd.0003398.e267.jpg"/></inline-formula> (for instance if the typical duration of the outbreak is <inline-formula><inline-graphic xlink:href="pntd.0003398.e268.jpg"/></inline-formula> days, <italic>i.e.</italic> including while <inline-formula><inline-graphic xlink:href="pntd.0003398.e269.jpg"/></inline-formula> was at the hospital, we found that <inline-formula><inline-graphic xlink:href="pntd.0003398.e270.jpg"/></inline-formula> instead of <inline-formula><inline-graphic xlink:href="pntd.0003398.e271.jpg"/></inline-formula> while the estimates based on the intersection with the <inline-formula><inline-graphic xlink:href="pntd.0003398.e272.jpg"/></inline-formula>-percentile and <inline-formula><inline-graphic xlink:href="pntd.0003398.e273.jpg"/></inline-formula>-percentile were <inline-formula><inline-graphic xlink:href="pntd.0003398.e274.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e275.jpg"/></inline-formula> respectively rather than <inline-formula><inline-graphic xlink:href="pntd.0003398.e276.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e277.jpg"/></inline-formula>), which reinforces the key message of this current work that a significant proportion of cases of LF arises from human-to-human transmission.</p></sec><sec id="s3d2"><title>Effect of the distribution of the generation times</title><p>The robustness of the approach was tested by considering different distributions for the generation time. We considered i) the distribution of generation time arising from the entire network, ii) the distribution arising from the particular subset of the data corresponding to the extra-nosocomial cases <inline-formula><inline-graphic xlink:href="pntd.0003398.e278.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e279.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e280.jpg"/></inline-formula>, <inline-formula><inline-graphic xlink:href="pntd.0003398.e281.jpg"/></inline-formula> and <inline-formula><inline-graphic xlink:href="pntd.0003398.e282.jpg"/></inline-formula>, iii) a gamma distribution with the same empirical mean and variance, iv) the empirical distribution by removing part of the tail, v) a &#x02018;stretched&#x02019; distribution by multiplying the empirical generation times by a factor <inline-formula><inline-graphic xlink:href="pntd.0003398.e283.jpg"/></inline-formula> to allow for a longer shedding of the virus, and vi) a &#x02018;shrunk&#x02019; distribution by multiplying the empirical generation times by a factor <inline-formula><inline-graphic xlink:href="pntd.0003398.e284.jpg"/></inline-formula>. In general, each of these methods had limited effects on the predictions (see S2 Figure in <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>, S3 Figure in <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>, S4 Figure in <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>, and S5 Figure in <xref ref-type="supplementary-material" rid="pntd.0003398.s002">S2 Text</xref>).</p></sec></sec></sec><sec id="s4"><title>Discussion</title><p>Disentangling the contribution of different hosts in spreading a zoonotic, emerging disease is a key challenge for determining effective, proportionate public health and safety measures. Such a conundrum has steered a scientific debate on LF, which appears to fluctuate around whether or not human-to-human transmission plays a major role compared to rodent-to-human transmission. The current work reconciles these two opposing paradigms. Here, we adopted a relatively simple mathematical approach to analyze data of hospitalized patients in KGH, Sierra Leone. The daily mean effective reproduction numbers, <inline-formula><inline-graphic xlink:href="pntd.0003398.e285.jpg"/></inline-formula>, observed in the nosocomial outbreaks (only human-to-human transmission) are much larger, and thus incompatible, with the ones estimated from the data from KGH, even if we assume <inline-formula><inline-graphic xlink:href="pntd.0003398.e286.jpg"/></inline-formula> human-to-human transmission. If we regard the extra-nosocomial cases observed in the Jos outbreak as representative of disease transmission in an endemic area, then a significant proportion of LF cases (<inline-formula><inline-graphic xlink:href="pntd.0003398.e287.jpg"/></inline-formula>) arise from human-to-human transmission. A significant proportion of these secondary cases, however, are attributable to a few events with disproportionately large effective reproduction numbers: super-spreading events. In general, the distributions of the individual reproductive number, <inline-formula><inline-graphic xlink:href="pntd.0003398.e288.jpg"/></inline-formula>, and the average number of cases during an epidemic, <inline-formula><inline-graphic xlink:href="pntd.0003398.e289.jpg"/></inline-formula>, exhibits a tail heavier than the exponential or Poisson distributions, here used as benchmarks for thin-tailed distributions. This reveal over-dispersion indicating the presence of super-spreading events.</p><p>These results have implications for clinical practice and policy. Super-spreading occurrences appear not to be exceptional for infectious diseases <xref rid="pntd.0003398-LloydSmith1" ref-type="bibr">[46]</xref>, <xref rid="pntd.0003398-Blumberg1" ref-type="bibr">[47]</xref>. According to this perspective, the lack of recorded secondary cases in Britain after the importation of confirmed cases of LF <xref rid="pntd.0003398-Cooper1" ref-type="bibr">[7]</xref>, <xref rid="pntd.0003398-Banatvala1" ref-type="bibr">[12]</xref> should not be regarded as proof of absence of human-to-human transmission. Any future assessment of the associated risk of LF and formulation of patient containment guidelines <xref rid="pntd.0003398-Advisory1" ref-type="bibr">[13]</xref>, therefore, should take into account the fat-tail nature of the underlying distribution of individual reproduction number.</p><p>Super-spreading events have been documented for many infectious diseases <xref rid="pntd.0003398-Stein1" ref-type="bibr">[45]</xref>, <xref rid="pntd.0003398-LloydSmith1" ref-type="bibr">[46]</xref>, including tuberculosis <xref rid="pntd.0003398-Kline1" ref-type="bibr">[48]</xref>, measles <xref rid="pntd.0003398-Paunio1" ref-type="bibr">[49]</xref> and SARS <xref rid="pntd.0003398-Riley1" ref-type="bibr">[50]</xref>&#x02013;<xref rid="pntd.0003398-Shen1" ref-type="bibr">[52]</xref>. The underlying reasons for super-spreading are not fully understood, but include amount of pathogen excreted, length of the infectious period, social behavior and environmental factors. Understanding the mechanisms of super-spreaders in LF requires an understanding of all of these factors, but transmission of LASV is not well characterized. In the Jos outbreak, Carey et al. <xref rid="pntd.0003398-Carey1" ref-type="bibr">[2]</xref> speculated that the severe pulmonary involvement of the index case and the location of her bed could cause airborne spread of virus to the rest of the ward. The long persistence of viruria, even during the recovery period, could facilitate transmission of LASV to other people or to the rodent reservoir host, especially in rural settlements in areas of West Africa where sanitary facilities are limited. Participatory modeling and ethnographic research <xref rid="pntd.0003398-Leach1" ref-type="bibr">[53]</xref> would be an invaluable tool to assess the variety of practices and settings in which people come into contact with each other's urine and other body fluids, perceptions of risk, and approaches to hygiene. Apart the work of Stephenson <italic>et al.</italic>
<xref rid="pntd.0003398-Stephenson1" ref-type="bibr">[17]</xref> and Peter <italic>et al.</italic>
<xref rid="pntd.0003398-Peters1" ref-type="bibr">[18]</xref>, we are not aware of specific experiments aimed to test routes of LASV transmission. Studies on environmental contamination are also required to explore if human-to-rodent transmission is important for the maintenance or spread of LASV infection <xref rid="pntd.0003398-FichetCalvet1" ref-type="bibr">[6]</xref>.</p><sec id="s4a"><title>Limitations of this study and future work</title><p>The current model is based on the assumption that the distribution of the generation times observed in the extra-nosocomial outbreak is representative of the generation times in the Sierra Leonean situations. This is probably reasonable, but public health measures may impact on this in the future. The predictions are based on the assumption of uniform mixing, <italic>i.e.</italic> each case from KGH is potentially in contact with each other case. Although this is a reasonable assumption, considering the large human mobility in Sierra Leone, for livelihoods, work and trade, social visits and events <xref rid="pntd.0003398-Leach2" ref-type="bibr">[54]</xref>, it will overestimate <inline-formula><inline-graphic xlink:href="pntd.0003398.e290.jpg"/></inline-formula>. In addition, there is likely to be incomplete reporting which will underestimate <inline-formula><inline-graphic xlink:href="pntd.0003398.e291.jpg"/></inline-formula>. Although the two factors might compensate for each other, if KGH could reduce reporting bias and increase information on network contacts, it would be highly beneficial to studies such as this, especially as human mobility and overcrowding has been associated with an amplification of LF <xref rid="pntd.0003398-Allan1" ref-type="bibr">[31]</xref>. This represents a further area where participatory modeling/ethnographic research is much needed to gather information on actual patterns of mobility and social networking, and hence potential contact patterns.</p><p>Other methods are possible, for example cluster-based inference of the reproduction number (see <italic>e.g.</italic>
<xref rid="pntd.0003398-Gay1" ref-type="bibr">[55]</xref>, <xref rid="pntd.0003398-Farrington1" ref-type="bibr">[56]</xref>) is a promising approach. In the current context, Kern&#x000e9;is <italic>et al.</italic>
<xref rid="pntd.0003398-Kernis1" ref-type="bibr">[20]</xref> provided detailed information on prevalence and risk factors of Lassa (<italic>e.g.</italic> history of collecting, cutting and eating rats) stratified by age. In addition, the age distribution from KGH is also available. These data could be combined together to build a matrix of transmission rates among age-groups (as done in <xref rid="pntd.0003398-Gay1" ref-type="bibr">[55]</xref>, <xref rid="pntd.0003398-Farrington1" ref-type="bibr">[56]</xref>) and between rodents and each age-group with values based on the findings of Kern&#x000e9;is <italic>et al.</italic>
<xref rid="pntd.0003398-Kernis1" ref-type="bibr">[20]</xref>.</p><p>For the KGH data, the difference in time of onset of symptoms was approximated here with the difference in time of visit/referral to the hospital following disease onset. This assumption can be an important source of error as patterns of health seeking behavior might vary largely among the Sierra Leonean population. For example, a particular group of the population might favor traditional medicine and approach institutional health care only at a late stage of the disease. Patients from rural areas might be subjected to further delay due to poor infrastructure. Health seeking behavior is perhaps one the most fruitful areas where participatory modeling and ethnographic research have been successfully employed and should be considered in the present context.</p><p>The estimations here are based on the assumption that probability of cross-species transmission occurs at random throughout outbreaks, although these events are expected to be strongly driven by a multitude of interacting causes, including ecological (<italic>e.g.</italic> seasonality in the abundance of the reservoir), epidemiological (<italic>e.g.</italic> seasonality in the prevalence of the pathogen), genetic variation (<italic>e.g.</italic> broad set of pathogen life histories) and socio-economic (<italic>e.g.</italic> the practice of burning the fields after harvesting affecting the ecology and dispersal patterns of <italic>M. natalensis</italic>) factors.</p><p>The estimation of the proportion of human-to-human transmission was based on the assumption that the typical duration of a chain of transmission is equal to the duration of the extra-nosocomial outbreak. As this information was only approximately known, we made the prudent choice that the duration of the extra-nosocomial outbreak was the entire extent of the outbreak in Jos, which was the maximum value from the data available. This led to a conservative estimation of <inline-formula><inline-graphic xlink:href="pntd.0003398.e292.jpg"/></inline-formula>. Despite some inevitable inaccuracies, all of our alternative/additional tests confirm that a significant proportion (in the region of <inline-formula><inline-graphic xlink:href="pntd.0003398.e293.jpg"/></inline-formula> or greater) of the burden of LF is due to human-to-human transmission.</p><p>The basis of our work is that, to the best of our knowledge, the nosocomial and extra-nosocomial outbreaks in Jos and Zorzor were instances of pure human-to-human chains. This is a message too important to be neglected. Despite some improvement in the implementation of barrier nursing in hospital structures, there is no evidence that in the last decades prophylactic measures have significantly changed in ordinary situations as in households and villages, and this issue has been abundantly clear during the current Ebola outbreak in West Africa. It is therefore reasonable that chains of human-to-human transmission, like the extra-nosocomial outbreak that occurred in Jos more than 40 years ago are much more common than expected.</p><p>This study highlights the need for integrated One Health approaches to model zoonoses more effectively in order to better-inform disease control and prevention. Zoonoses remain a neglected group of diseases, under-prioritised in national and international health systems.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pntd.0003398.s001"><label>S1 Text</label><caption><p>List of symbols and glossary.</p><p>(PDF)</p></caption><media xlink:href="pntd.0003398.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0003398.s002"><label>S2 Text</label><caption><p>Details on the nosocomial outbreaks and further tests.</p><p>(PDF)</p></caption><media xlink:href="pntd.0003398.s002.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pntd.0003398.s003"><label>S1 Data</label><caption><p>The file provides the daily number of referred/visiting patients at KGH (confirmed cases only) from the <inline-formula><inline-graphic xlink:href="pntd.0003398.e294.jpg"/></inline-formula> of April <inline-formula><inline-graphic xlink:href="pntd.0003398.e295.jpg"/></inline-formula> to the <inline-formula><inline-graphic xlink:href="pntd.0003398.e296.jpg"/></inline-formula> of January <inline-formula><inline-graphic xlink:href="pntd.0003398.e297.jpg"/></inline-formula>
<xref rid="pntd.0003398-Shaffer1" ref-type="bibr">[1]</xref>, as displayed in <xref ref-type="fig" rid="pntd-0003398-g002">Fig. 2</xref>.</p><p>(TXT)</p></caption><media xlink:href="pntd.0003398.s003.txt"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>This paper is dedicated to the memory of our co-author Dr. Sheik Humarr Khan, who has recently died from Ebola virus. Dr. Khan was a leading doctor on the front lines fighting the Ebola outbreak in Sierra Leone. His dedication, courage and abnegation have been greatly recognized by the medical community and Sierra Leonean authorities who called Dr. Khan a &#x0201c;national hero&#x0201d; for his tremendous sacrifice in working to save the lives of more than 100 infected patients.</p></ack><ref-list><title>References</title><ref id="pntd.0003398-Shaffer1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Shaffer</surname><given-names>JG</given-names></name>, <name><surname>Grant</surname><given-names>DS</given-names></name>, <name><surname>Schieffelin</surname><given-names>JS</given-names></name>, <name><surname>Boisen</surname><given-names>ML</given-names></name>, <name><surname>Goba</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2014</year>) <article-title>Lassa fever in post-conflict Sierra Leone</article-title>. <source>PLoS Neglected Tropical Diseases</source>
<volume>8</volume>: <fpage>e2748</fpage>.<pub-id pub-id-type="pmid">24651047</pub-id></mixed-citation></ref><ref id="pntd.0003398-Carey1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Carey</surname><given-names>D</given-names></name>, <name><surname>Kemp</surname><given-names>G</given-names></name>, <name><surname>White</surname><given-names>H</given-names></name>, <name><surname>Pinneo</surname><given-names>L</given-names></name>, <name><surname>Addy</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>1972</year>) <article-title>Lassa fever epidemiological aspects of the 1970 epidemic, Jos, Nigeria</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>
<volume>66</volume>: <fpage>402</fpage>&#x02013;<lpage>408</lpage>.<pub-id pub-id-type="pmid">5046380</pub-id></mixed-citation></ref><ref id="pntd.0003398-Monath1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Monath</surname><given-names>TP</given-names></name>, <name><surname>Mertens</surname><given-names>PE</given-names></name>, <name><surname>Patton</surname><given-names>R</given-names></name>, <name><surname>Moser</surname><given-names>CR</given-names></name>, <name><surname>Baum</surname><given-names>JJ</given-names></name>, <etal>et al</etal> (<year>1973</year>) <article-title>A hospital epidemic of Lassa fever in Zorzor, Liberia, March&#x02013;April 1972</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>22</volume>: <fpage>773</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">4745236</pub-id></mixed-citation></ref><ref id="pntd.0003398-Frame1"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Frame</surname><given-names>JD</given-names></name>, <name><surname>Baldwin</surname><given-names>JM</given-names></name>, <name><surname>Gocke</surname><given-names>DJ</given-names></name>, <name><surname>Troup</surname><given-names>JM</given-names></name> (<year>1970</year>) <article-title>Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>19</volume>: <fpage>670</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">4246571</pub-id></mixed-citation></ref><ref id="pntd.0003398-Rose1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Rose</surname><given-names>J</given-names></name> (<year>1957</year>) <article-title>An outbreak of encephalomyelitis in Sierra Leone</article-title>. <source>The Lancet</source>
<volume>270</volume>: <fpage>914</fpage>&#x02013;<lpage>916</lpage>.</mixed-citation></ref><ref id="pntd.0003398-FichetCalvet1"><label>6</label><mixed-citation publication-type="other">Fichet-Calvet E (2014) Lassa Fever. In: The Role of Animals in Emerging Viral Diseases, Academic Press. pp.89&#x02013;123.</mixed-citation></ref><ref id="pntd.0003398-Cooper1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Cooper</surname><given-names>CB</given-names></name>, <name><surname>Gransden</surname><given-names>WR</given-names></name>, <name><surname>Webster</surname><given-names>M</given-names></name>, <name><surname>King</surname><given-names>M</given-names></name>, <name><surname>O&#x02032;Mahony</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1982</year>) <article-title>A case of Lassa fever: experience at St Thomas's Hospital</article-title>. <source>British Medical Journal (Clinical Research Edition)</source>
<volume>285</volume>: <fpage>212</fpage>.</mixed-citation></ref><ref id="pntd.0003398-Monath2"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Monath</surname><given-names>TP</given-names></name>, <name><surname>Newhouse</surname><given-names>VF</given-names></name>, <name><surname>Kemp</surname><given-names>GE</given-names></name>, <name><surname>Setzer</surname><given-names>HW</given-names></name>, <name><surname>Cacciapuoti</surname><given-names>A</given-names></name> (<year>1974</year>) <article-title>Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone</article-title>. <source>Science</source>
<volume>185</volume>: <fpage>263</fpage>&#x02013;<lpage>265</lpage>.<pub-id pub-id-type="pmid">4833828</pub-id></mixed-citation></ref><ref id="pntd.0003398-FisherHoch1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Fisher-Hoch</surname><given-names>S</given-names></name>, <name><surname>Craven</surname><given-names>R</given-names></name>, <name><surname>Forthall</surname><given-names>D</given-names></name>, <name><surname>Scott</surname><given-names>S</given-names></name>, <name><surname>Price</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1985</year>) <article-title>Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques</article-title>. <source>The Lancet</source>
<volume>326</volume>: <fpage>1227</fpage>&#x02013;<lpage>1229</lpage>.</mixed-citation></ref><ref id="pntd.0003398-Helmick1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Helmick</surname><given-names>C</given-names></name>, <name><surname>Scribner</surname><given-names>C</given-names></name>, <name><surname>Webb</surname><given-names>P</given-names></name>, <name><surname>Krebs</surname><given-names>J</given-names></name>, <name><surname>McCormick</surname><given-names>J</given-names></name> (<year>1986</year>) <article-title>No evidence for increased risk of Lassa fever infection in hospital staff</article-title>. <source>The Lancet</source>
<volume>328</volume>: <fpage>1202</fpage>&#x02013;<lpage>1205</lpage>.</mixed-citation></ref><ref id="pntd.0003398-Holmes1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Holmes</surname><given-names>GP</given-names></name>, <name><surname>McCormick</surname><given-names>JB</given-names></name>, <name><surname>Trock</surname><given-names>SC</given-names></name>, <name><surname>Chase</surname><given-names>RA</given-names></name>, <name><surname>Lewis</surname><given-names>SM</given-names></name>, <etal>et al</etal> (<year>1990</year>) <article-title>Lassa fever in the United States. Investigation of a case and new guidelines for management</article-title>. <source>The New England Journal of Medicine</source>
<volume>323</volume>: <fpage>1120</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">2215580</pub-id></mixed-citation></ref><ref id="pntd.0003398-Banatvala1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Banatvala</surname><given-names>JE</given-names></name> (<year>1986</year>) <article-title>Lassa fever</article-title>. <source>British Medical Journal</source>
<volume>293</volume>: <fpage>1256</fpage>&#x02013;<lpage>1257</lpage>.<pub-id pub-id-type="pmid">3096456</pub-id></mixed-citation></ref><ref id="pntd.0003398-Advisory1"><label>13</label><mixed-citation publication-type="other">Advisory Committee on Dangerous Pathogens (2012). Management and control of viral haemorrhagic fevers (ACDP).</mixed-citation></ref><ref id="pntd.0003398-Haas1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Haas</surname><given-names>WH</given-names></name>, <name><surname>Breuer</surname><given-names>T</given-names></name>, <name><surname>Pfaff</surname><given-names>G</given-names></name>, <name><surname>Schmitz</surname><given-names>H</given-names></name>, <name><surname>K&#x000f6;hler</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Imported Lassa fever in Germany: surveillance and management of contact persons</article-title>. <source>Clinical Infectious Diseases: an official publication of the Infectious Diseases Society of America</source>
<volume>36</volume>: <fpage>1254</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">12746770</pub-id></mixed-citation></ref><ref id="pntd.0003398-Emond1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Emond</surname><given-names>RT</given-names></name>, <name><surname>Weir</surname><given-names>WR</given-names></name>, <name><surname>Bowen</surname><given-names>ET</given-names></name>, <name><surname>Lloyd</surname><given-names>G</given-names></name>, <name><surname>Southee</surname><given-names>T</given-names></name> (<year>1984</year>) <article-title>Managing Lassa fever</article-title>. <source>Lancet</source>
<volume>2</volume>: <fpage>926</fpage>.</mixed-citation></ref><ref id="pntd.0003398-Monath3"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Monath</surname><given-names>TP</given-names></name> (<year>1975</year>) <article-title>Lassa fever: review of epidemiology and epizootiology</article-title>. <source>Bulletin of the World Health Organization</source>
<volume>52</volume>: <fpage>577</fpage>&#x02013;<lpage>592</lpage>.<pub-id pub-id-type="pmid">782738</pub-id></mixed-citation></ref><ref id="pntd.0003398-Stephenson1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Stephenson</surname><given-names>EH</given-names></name>, <name><surname>Larson</surname><given-names>EW</given-names></name>, <name><surname>Dominik</surname><given-names>JW</given-names></name> (<year>1984</year>) <article-title>Effect of environmental factors on aerosol-induced Lassa virus infection</article-title>. <source>Journal of Medical Virology</source>
<volume>14</volume>: <fpage>295</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="pmid">6512508</pub-id></mixed-citation></ref><ref id="pntd.0003398-Peters1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Peters</surname><given-names>CJ</given-names></name>, <name><surname>Jahrling</surname><given-names>PB</given-names></name>, <name><surname>Liu</surname><given-names>CT</given-names></name>, <name><surname>Kenyon</surname><given-names>RH</given-names></name>, <name><surname>McKee</surname><given-names>KT</given-names></name>, <etal>et al</etal> (<year>1987</year>) <article-title>Experimental studies of arenaviral hemorrhagic fevers</article-title>. <source>Current Topics in Microbiology and Immunology</source>
<volume>134</volume>: <fpage>5</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">3034512</pub-id></mixed-citation></ref><ref id="pntd.0003398-Sagripanti1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Sagripanti</surname><given-names>JL</given-names></name>, <name><surname>Rom</surname><given-names>AM</given-names></name>, <name><surname>Holland</surname><given-names>LE</given-names></name> (<year>2010</year>) <article-title>Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces</article-title>. <source>Archives of Virology</source>
<volume>155</volume>: <fpage>2035</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">20842393</pub-id></mixed-citation></ref><ref id="pntd.0003398-Kernis1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Kern&#x000e9;is</surname><given-names>S</given-names></name>, <name><surname>Koivogui</surname><given-names>L</given-names></name>, <name><surname>Magassouba</surname><given-names>N</given-names></name>, <name><surname>Koulemou</surname><given-names>K</given-names></name>, <name><surname>Lewis</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study</article-title>. <source>PLoS Neglected Tropical Diseases</source>
<volume>3</volume>: <fpage>e548</fpage>.<pub-id pub-id-type="pmid">19924222</pub-id></mixed-citation></ref><ref id="pntd.0003398-McCormick1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>McCormick</surname><given-names>JB</given-names></name>, <name><surname>Webb</surname><given-names>PA</given-names></name>, <name><surname>Krebs</surname><given-names>JW</given-names></name>, <name><surname>Johnson</surname><given-names>KM</given-names></name>, <name><surname>Smith</surname><given-names>ES</given-names></name> (<year>1987</year>) <article-title>A Prospective study of the epidemiology and ecology of Lassa fever</article-title>. <source>The Journal of Infectious Diseases</source>
<volume>155</volume>: <fpage>437</fpage>&#x02013;<lpage>444</lpage>.<pub-id pub-id-type="pmid">3805771</pub-id></mixed-citation></ref><ref id="pntd.0003398-Briese1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Briese</surname><given-names>T</given-names></name>, <name><surname>Paweska</surname><given-names>JT</given-names></name>, <name><surname>McMullan</surname><given-names>LK</given-names></name>, <name><surname>Hutchison</surname><given-names>SK</given-names></name>, <name><surname>Street</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa</article-title>. <source>PLoS Pathogens</source>
<volume>5</volume>: <fpage>e1000455</fpage>.<pub-id pub-id-type="pmid">19478873</pub-id></mixed-citation></ref><ref id="pntd.0003398-Crowcroft1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Crowcroft</surname><given-names>NS</given-names></name>, <name><surname>Meltzer</surname><given-names>M</given-names></name>, <name><surname>Evans</surname><given-names>M</given-names></name>, <name><surname>Shetty</surname><given-names>N</given-names></name>, <name><surname>Maguire</surname><given-names>H</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>The public health response to a case of Lassa fever in London in 2000</article-title>. <source>The Journal of Infection</source>
<volume>48</volume>: <fpage>221</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15001300</pub-id></mixed-citation></ref><ref id="pntd.0003398-Macher1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Macher</surname><given-names>AM</given-names></name>, <name><surname>Wolfe</surname><given-names>MS</given-names></name> (<year>2006</year>) <article-title>Historical Lassa fever reports and 30-year clinical update</article-title>. <source>Emerging Infectious Diseases</source>
<volume>12</volume>: <fpage>835</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">16704848</pub-id></mixed-citation></ref><ref id="pntd.0003398-Woodrow1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Woodrow</surname><given-names>CJ</given-names></name>, <name><surname>Eziefula</surname><given-names>AC</given-names></name>, <name><surname>Agranoff</surname><given-names>D</given-names></name>, <name><surname>Scott</surname><given-names>GM</given-names></name>, <name><surname>Watson</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Early risk assessment for viral haemorrhagic fever: experience at the Hospital for Tropical Diseases, London, UK</article-title>. <source>The Journal of Infection</source>
<volume>54</volume>: <fpage>6</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">16549203</pub-id></mixed-citation></ref><ref id="pntd.0003398-Atkin1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Atkin</surname><given-names>S</given-names></name>, <name><surname>Anaraki</surname><given-names>S</given-names></name>, <name><surname>Gothard</surname><given-names>P</given-names></name>, <name><surname>Walsh</surname><given-names>A</given-names></name>, <name><surname>Brown</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>The first case of Lassa fever imported from Mali to the United Kingdom, february 2009</article-title>. <source>Eurosurveillance</source>
<volume>14</volume>: <fpage>1</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="pntd.0003398-Kitching1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Kitching</surname><given-names>A</given-names></name>, <name><surname>Addiman</surname><given-names>S</given-names></name>, <name><surname>Cathcart</surname><given-names>S</given-names></name>, <name><surname>Bishop</surname><given-names>L</given-names></name>, <name><surname>Krah&#x000e9;</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>A fatal case of Lassa fever in London, January 2009</article-title>. <source>Eurosurveillance</source>
<volume>14</volume>: <fpage>1</fpage>&#x02013;<lpage>3</lpage>.</mixed-citation></ref><ref id="pntd.0003398-Beeching1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Beeching</surname><given-names>NJ</given-names></name>, <name><surname>Fletcher</surname><given-names>TE</given-names></name>, <name><surname>Hill</surname><given-names>DR</given-names></name>, <name><surname>Thomson</surname><given-names>GL</given-names></name> (<year>2010</year>) <article-title>Travellers and viral haemorrhagic fevers: what are the risks?</article-title>
<source>International Journal of Antimicrobial Agents</source>
<volume>36</volume>
<issue>Suppl 1</issue>: <fpage>S26</fpage>&#x02013;<lpage>35</lpage>.</mixed-citation></ref><ref id="pntd.0003398-Wallinga1"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Wallinga</surname><given-names>J</given-names></name>, <name><surname>Teunis</surname><given-names>P</given-names></name> (<year>2004</year>) <article-title>Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures</article-title>. <source>American Journal of Epidemiology</source>
<volume>160</volume>: <fpage>509</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">15353409</pub-id></mixed-citation></ref><ref id="pntd.0003398-Obadia1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Obadia</surname><given-names>T</given-names></name>, <name><surname>Haneef</surname><given-names>R</given-names></name>, <name><surname>Bo&#x000eb;lle</surname><given-names>PY</given-names></name> (<year>2012</year>) <article-title>The R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks</article-title>. <source>BMC Medical Informatics and Decision Making</source>
<volume>12</volume>: <fpage>147</fpage>.<pub-id pub-id-type="pmid">23249562</pub-id></mixed-citation></ref><ref id="pntd.0003398-Allan1"><label>31</label><mixed-citation publication-type="other">Allan R, Mardell S, Ladbury R, Pearce E, Skinner K (1999) The progression from endemic to epidemic Lassa fever in war-torn West Africa. In: Saluzzo J.F. and Dodet B. editors, Factors in the Emergence and Control of Rodent-borne Viral Diseases, Elsevier. pp.197&#x02013;205.</mixed-citation></ref><ref id="pntd.0003398-McCormick2"><label>32</label><mixed-citation publication-type="other">McCormick J.B., Fisher-Hoch M (2002) Lassa Fever. In: Oldstone MBA, editor, Arenaviruses: The Epidemiology, Molecular and Cell Biology of Arenaviruses, Springer Berlin Heidelberg. pp.75&#x02013;109.</mixed-citation></ref><ref id="pntd.0003398-Bowen1"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Bowen</surname><given-names>MD</given-names></name>, <name><surname>Rollin</surname><given-names>PE</given-names></name>, <name><surname>Ksiazek</surname><given-names>TG</given-names></name>, <name><surname>Hustad</surname><given-names>HL</given-names></name>, <name><surname>Bausch</surname><given-names>DG</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>Genetic diversity among Lassa virus strains</article-title>. <source>Journal Of Virology</source>
<volume>74</volume>: <fpage>6992</fpage>&#x02013;<lpage>7004</lpage>.<pub-id pub-id-type="pmid">10888638</pub-id></mixed-citation></ref><ref id="pntd.0003398-YalleyOgunro1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Yalley-Ogunro</surname><given-names>JE</given-names></name>, <name><surname>Frame</surname><given-names>JD</given-names></name>, <name><surname>Hanson</surname><given-names>AP</given-names></name> (<year>1984</year>) <article-title>Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia</article-title>. <source>Transactions of the Royal Society of Tropical Medicine and Hygiene</source>
<volume>78</volume>: <fpage>764</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">6398530</pub-id></mixed-citation></ref><ref id="pntd.0003398-Tomori1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Tomori</surname><given-names>O</given-names></name>, <name><surname>Fabiyi</surname><given-names>A</given-names></name>, <name><surname>Sorungbe</surname><given-names>A</given-names></name>, <name><surname>Smith</surname><given-names>A</given-names></name>, <name><surname>McCormick</surname><given-names>JB</given-names></name> (<year>1988</year>) <article-title>Viral hemorrhagic fever antibodies in Nigerian populations</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>38</volume>: <fpage>407</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">3128130</pub-id></mixed-citation></ref><ref id="pntd.0003398-Boiro1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Boiro</surname><given-names>I</given-names></name>, <name><surname>Lomonossov</surname><given-names>NN</given-names></name>, <name><surname>Sotsinski</surname><given-names>VA</given-names></name>, <name><surname>Constantinov</surname><given-names>OK</given-names></name>, <name><surname>Tkachenko</surname><given-names>EA</given-names></name>, <etal>et al</etal> (<year>1987</year>) <article-title>Clinico-epidemiologic and laboratory research on hemorrhagic fevers in Guinea</article-title>. <source>Bulletin de la Soci&#x000e9;t&#x000e9; de Pathologie Exotique et de ses Filiales</source>
<volume>80</volume>: <fpage>607</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">3440310</pub-id></mixed-citation></ref><ref id="pntd.0003398-Lukashevich1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Lukashevich</surname><given-names>IS</given-names></name>, <name><surname>Clegg</surname><given-names>JCS</given-names></name>, <name><surname>Sidibe</surname><given-names>K</given-names></name> (<year>1993</year>) <article-title>Lassa virus activity in Guinea: distribution of human antiviral antibody defined using enzyme-linked immunosorbent assay with recombinant antigen</article-title>. <source>Journal of Medical Virology</source>
<volume>40</volume>: <fpage>210</fpage>&#x02013;<lpage>217</lpage>.<pub-id pub-id-type="pmid">8355019</pub-id></mixed-citation></ref><ref id="pntd.0003398-TerMeulen1"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Ter Meulen</surname><given-names>J</given-names></name>, <name><surname>Lukashevich</surname><given-names>I</given-names></name>, <name><surname>Sidibe</surname><given-names>K</given-names></name>, <name><surname>Inapogui</surname><given-names>A</given-names></name>, <name><surname>Marx</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>Hunting of peridomestic rodents and consumption of their meat as possible risk factors for rodent-to-human transmission of Lassa virus in the Republic of Guinea</article-title>. <source>The American Journal of Tropical Medicine and Hygiene</source>
<volume>55</volume>: <fpage>661</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">9025695</pub-id></mixed-citation></ref><ref id="pntd.0003398-AkouaKoffi1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Akoua-Koffi</surname><given-names>C</given-names></name>, <name><surname>Ter Meulen</surname><given-names>J</given-names></name>, <name><surname>Legros</surname><given-names>D</given-names></name>, <name><surname>Akran</surname><given-names>V</given-names></name>, <name><surname>A&#x000ef;dara</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Detection of anti-Lassa antibodies in the Western Forest area of the Ivory Coast</article-title>. <source>M&#x000e9;decine Tropicale: Revue du Corps de Sant&#x000e9; Colonial</source>
<volume>66</volume>: <fpage>465</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">17201291</pub-id></mixed-citation></ref><ref id="pntd.0003398-Klempa1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Klempa</surname><given-names>B</given-names></name>, <name><surname>Koulemou</surname><given-names>K</given-names></name>, <name><surname>Auste</surname><given-names>B</given-names></name>, <name><surname>Emmerich</surname><given-names>P</given-names></name>, <name><surname>Thom&#x000e9;-Bolduan</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Seroepidemiological study reveals regional co-occurrence of Lassa- and Hantavirus antibodies in Upper Guinea, West Africa</article-title>. <source>Tropical Medicine &#x00026; International Health</source>
<volume>18</volume>: <fpage>366</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="pmid">23279760</pub-id></mixed-citation></ref><ref id="pntd.0003398-FisherHoch2"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Fisher-Hoch</surname><given-names>SP</given-names></name>, <name><surname>Tomori</surname><given-names>O</given-names></name>, <name><surname>Nasidi</surname><given-names>A</given-names></name>, <name><surname>Perez-Oronoz</surname><given-names>GI</given-names></name>, <name><surname>Fakile</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>1995</year>) <article-title>Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice</article-title>. <source>British Medical Journal (Clinical Research Edition)</source>
<volume>311</volume>: <fpage>857</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="pntd.0003398-Tobin1"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Tobin</surname><given-names>E</given-names></name>, <name><surname>Asogun</surname><given-names>D</given-names></name>, <name><surname>Isah</surname><given-names>E</given-names></name>, <name><surname>Ugege</surname><given-names>O</given-names></name>, <name><surname>Ebhodaghe</surname><given-names>P</given-names></name> (<year>2013</year>) <article-title>Assessment of knowledge and attitude towards Lassa fever among primary care providers in an endemic suburban community of Edo state: implications for control</article-title>. <source>Journal of Medicine and Medical Sciences</source>
<volume>4</volume>: <fpage>311</fpage>&#x02013;<lpage>318</lpage>.</mixed-citation></ref><ref id="pntd.0003398-FisherHoch3"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Fisher-Hoch</surname><given-names>SP</given-names></name> (<year>2005</year>) <article-title>Lessons from nosocomial viral haemorrhagic fever outbreaks</article-title>. <source>British Medical Bulletin</source>
<volume>73-74</volume>: <fpage>123</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">16373655</pub-id></mixed-citation></ref><ref id="pntd.0003398-R1"><label>44</label><mixed-citation publication-type="other">R Development Core Team (2011) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. URL <ext-link ext-link-type="uri" xlink:href="http://www.R-project.org/">http://www.R-project.org/</ext-link>. ISBN 3-900051-07-0.</mixed-citation></ref><ref id="pntd.0003398-Stein1"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Stein</surname><given-names>RA</given-names></name> (<year>2011</year>) <article-title>Super-spreaders in infectious diseases</article-title>. <source>International Journal of Infectious Diseases</source>
<volume>15</volume>: <fpage>e510</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">21737332</pub-id></mixed-citation></ref><ref id="pntd.0003398-LloydSmith1"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name>, <name><surname>Schreiber</surname><given-names>SJ</given-names></name>, <name><surname>Kopp</surname><given-names>PE</given-names></name>, <name><surname>Getz</surname><given-names>WM</given-names></name> (<year>2005</year>) <article-title>Superspreading and the effect of individual variation on disease emergence</article-title>. <source>Nature</source>
<volume>438</volume>: <fpage>355</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">16292310</pub-id></mixed-citation></ref><ref id="pntd.0003398-Blumberg1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Blumberg</surname><given-names>S</given-names></name>, <name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name> (<year>2013</year>) <article-title>Inference of <italic>R</italic>
<sub>0</sub> and transmission heterogeneity from the size distribution of stuttering chains</article-title>. <source>PLoS Computational Biology</source>
<volume>9</volume>: <fpage>e1002993</fpage>.<pub-id pub-id-type="pmid">23658504</pub-id></mixed-citation></ref><ref id="pntd.0003398-Kline1"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Kline</surname><given-names>SE</given-names></name>, <name><surname>Hedemark</surname><given-names>LL</given-names></name>, <name><surname>Davies</surname><given-names>SF</given-names></name> (<year>1995</year>) <article-title>Outbreak of tuberculosis among regular patrons of a neighborhood bar</article-title>. <source>The New England Journal of Medicine</source>
<volume>333</volume>: <fpage>222</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">7791838</pub-id></mixed-citation></ref><ref id="pntd.0003398-Paunio1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Paunio</surname><given-names>M</given-names></name>, <name><surname>Peltola</surname><given-names>H</given-names></name>, <name><surname>Valle</surname><given-names>M</given-names></name>, <name><surname>Davidkin</surname><given-names>I</given-names></name>, <name><surname>Virtanen</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees</article-title>. <source>American Journal of Epidemiology</source>
<volume>148</volume>: <fpage>1103</fpage>&#x02013;<lpage>1110</lpage>.<pub-id pub-id-type="pmid">9850133</pub-id></mixed-citation></ref><ref id="pntd.0003398-Riley1"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Riley</surname><given-names>S</given-names></name>, <name><surname>Fraser</surname><given-names>C</given-names></name>, <name><surname>Donnelly</surname><given-names>CA</given-names></name>, <name><surname>Ghani</surname><given-names>AC</given-names></name>, <name><surname>Abu-Raddad</surname><given-names>LJ</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions</article-title>. <source>Science (New York, NY)</source>
<volume>300</volume>: <fpage>1961</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="pntd.0003398-Lipsitch1"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Lipsitch</surname><given-names>M</given-names></name>, <name><surname>Cohen</surname><given-names>T</given-names></name>, <name><surname>Cooper</surname><given-names>B</given-names></name>, <name><surname>Robins</surname><given-names>JM</given-names></name>, <name><surname>Ma</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Transmission dynamics and control of severe acute respiratory syndrome</article-title>. <source>Science (New York, NY)</source>
<volume>300</volume>: <fpage>1966</fpage>&#x02013;<lpage>70</lpage>.</mixed-citation></ref><ref id="pntd.0003398-Shen1"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Shen</surname><given-names>Z</given-names></name>, <name><surname>Ning</surname><given-names>F</given-names></name>, <name><surname>Zhou</surname><given-names>W</given-names></name>, <name><surname>He</surname><given-names>X</given-names></name>, <name><surname>Lin</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Superspreading SARS events, Beijing, 2003</article-title>. <source>Emerging Infectious Diseases</source>
<volume>10</volume>: <fpage>256</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">15030693</pub-id></mixed-citation></ref><ref id="pntd.0003398-Leach1"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Leach</surname><given-names>M</given-names></name>, <name><surname>Scoones</surname><given-names>I</given-names></name> (<year>2013</year>) <article-title>The social and political lives of zoonotic disease models: narratives, science and policy</article-title>. <source>Social Science &#x00026; Medicine</source>
<volume>88</volume>: <fpage>10</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">23702205</pub-id></mixed-citation></ref><ref id="pntd.0003398-Leach2"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Leach</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Rainforest Relations: Gender and Resource Use Among the Mende of Gola, Sierra Leone</article-title>. <source>Edinburgh University Press</source>
<volume>272</volume> pp..</mixed-citation></ref><ref id="pntd.0003398-Gay1"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Gay</surname><given-names>NJ</given-names></name>, <name><surname>Hesketh</surname><given-names>LM</given-names></name>, <name><surname>Morgan-Capner</surname><given-names>P</given-names></name>, <name><surname>Miller</surname><given-names>E</given-names></name> (<year>1995</year>) <article-title>Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy</article-title>. <source>Epidemiology and Infection</source>
<volume>115</volume>: <fpage>139</fpage>&#x02013;<lpage>156</lpage>.<pub-id pub-id-type="pmid">7641827</pub-id></mixed-citation></ref><ref id="pntd.0003398-Farrington1"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Farrington</surname><given-names>CP</given-names></name>, <name><surname>Kanaan</surname><given-names>MN</given-names></name>, <name><surname>Gay</surname><given-names>NJ</given-names></name> (<year>2003</year>) <article-title>Branching process models for surveillance of infectious diseases controlled by mass vaccination</article-title>. <source>Biostatistics (Oxford, England)</source>
<volume>4</volume>: <fpage>279</fpage>&#x02013;<lpage>95</lpage>.</mixed-citation></ref></ref-list></back></article>